data_2jv2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jv2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.175 -0.306 . . . . 0.70999999999999996 110.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.71 110.031 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 2.5099999999999998 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 1.1699999999999999 110.328 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.72 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.55000000000000004 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 1.1499999999999999 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.34000000000000002 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 3.0899999999999999 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 1.26 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 1.3200000000000001 110.369 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.56999999999999995 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.51000000000000001 112.791 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.58999999999999997 111.186 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 1.4299999999999999 110.707 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 1.23 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 1.1299999999999999 109.94 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.93999999999999995 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 1.1100000000000001 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.73 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 1.22 111.587 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64000000000000001 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.27000000000000002 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 2.4900000000000002 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 1.03 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 1.03 110.43 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.98 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 1.0600000000000001 111.469 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 1.04 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 1.0900000000000001 110.281 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28000000000000003 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 1.1799999999999999 109.106 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.47 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 1.46 109.469 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 2.02 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.64000000000000001 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 3.1099999999999999 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.4199999999999999 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 1.1200000000000001 109.72 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 2.21 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.70999999999999996 110.185 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 2.02 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 1.02 109.062 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 1.0600000000000001 109.054 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.9299999999999999 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 1.02 109.917 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.85999999999999999 110.091 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.20999999999999999 110.257 -16.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.73999999999999999 109.835 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.46000000000000002 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 1.03 110.435 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 3.2599999999999998 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 1.0700000000000001 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.6799999999999999 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 4.1399999999999997 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.98999999999999999 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 2.0299999999999998 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 1.1699999999999999 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 1.1299999999999999 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 1.1399999999999999 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 1.1499999999999999 109.426 179.216 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 120.784 0.326 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.807 0.337 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.824 0.345 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 120.837 0.351 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.727 0.299 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.776 0.322 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.82 0.343 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.765 0.317 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.749 0.309 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.737 0.304 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.801 0.334 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.036 -0.357 . . . . 6.5800000000000001 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.51 168.34 38.1 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.529 -1.428 . . . . 3.73 109.529 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.83 137.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.191 -0.67 . . . . 3.2200000000000002 109.191 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -107.83 132.67 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.233 -0.655 . . . . 3.2400000000000002 109.233 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptm -145.6 120.77 10.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.217 -0.302 . . . . 2.6400000000000001 110.329 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p -100.43 155.26 17.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.138 -0.351 . . . . 0.70999999999999996 110.175 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.71 110.031 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 2.5099999999999998 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 1.1699999999999999 110.328 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.72 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.55000000000000004 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 1.1499999999999999 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.34000000000000002 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 3.0899999999999999 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 1.26 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 1.3200000000000001 110.369 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.56999999999999995 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.51000000000000001 112.791 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.58999999999999997 111.186 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 1.4299999999999999 110.707 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 1.23 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 1.1299999999999999 109.94 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.93999999999999995 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 1.1100000000000001 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.73 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 1.22 111.587 -167.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64000000000000001 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.27000000000000002 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 2.4900000000000002 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 1.03 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 1.03 110.43 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.98 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 1.0600000000000001 111.469 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 1.04 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 1.0900000000000001 110.281 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28000000000000003 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 1.1799999999999999 109.106 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.47 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 1.46 109.469 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 2.02 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.64000000000000001 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 3.1099999999999999 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.4199999999999999 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 1.1200000000000001 109.72 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 2.21 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.70999999999999996 110.185 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 2.02 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 1.02 109.062 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 1.0600000000000001 109.054 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.9299999999999999 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 1.02 109.917 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.85999999999999999 110.091 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.20999999999999999 110.257 -16.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.73999999999999999 109.835 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.46000000000000002 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 1.03 110.435 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 3.2599999999999998 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 1.0700000000000001 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.6799999999999999 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 4.1399999999999997 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.98999999999999999 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 2.0299999999999998 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 1.1699999999999999 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 1.1299999999999999 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 1.1399999999999999 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.77 137.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 1.1499999999999999 109.426 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.47 164.99 31.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.139 -0.351 . . . . 1.3400000000000001 110.242 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -99.71 154.94 37.0 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.328 -0.368 . . . . 5.5599999999999996 110.189 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 O-C-N 123.476 1.251 . . . . 4.7300000000000004 110.219 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 120.73 0.3 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.02 -140.09 3.17 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.95 130.77 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.1 mt -119.31 124.49 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -88.05 117.76 27.15 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.349 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p -76.89 148.34 36.5 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.988 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t -94.23 136.19 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.37 162.64 38.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.159 -0.338 . . . . 0.0 110.224 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -130.79 92.18 34.99 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.08 -0.388 . . . . 0.0 110.278 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.148 1.078 . . . . 0.0 110.693 179.801 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -140.01 30.57 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 131.47 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.033 -0.686 . . . . 0.0 109.258 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.8 mm -116.92 137.81 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -86.66 111.5 20.72 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.063 0.458 . . . . 0.0 110.378 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p -101.57 152.05 21.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.917 -0.489 . . . . 0.0 110.243 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t -94.91 143.61 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.0 p -148.02 -49.62 0.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.205 -0.309 . . . . 0.0 110.293 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -105.37 108.31 61.12 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.564 0 O-C-N 123.13 1.069 . . . . 0.0 110.736 178.804 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.68 -142.92 1.12 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.32 142.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -95.3 116.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptp -87.31 118.07 26.49 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.563 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p -105.37 145.64 30.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.955 -0.466 . . . . 0.0 110.158 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t -93.59 135.0 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -147.46 167.82 23.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.187 -0.32 . . . . 0.0 110.206 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -105.2 155.18 38.19 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.295 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 O-C-N 123.569 1.3 . . . . 0.0 110.261 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -158.17 1.49 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.17 133.78 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.84 129.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.8 ptp -86.07 114.18 22.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.108 0.48 . . . . 0.0 110.598 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -99.41 154.17 18.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.008 -0.432 . . . . 0.0 109.975 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.01 138.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.1 p -147.6 169.03 20.49 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.23 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -112.37 97.53 40.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 122.057 -0.402 . . . . 0.0 110.188 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.474 0 O-C-N 123.239 1.126 . . . . 0.0 110.67 179.195 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 70.09 2.51 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.2 138.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -106.28 124.46 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -87.62 116.58 25.84 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p -108.48 148.9 29.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.034 -0.416 . . . . 0.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t -93.76 134.82 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -147.71 33.22 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.788 0.328 . . . . 0.0 110.333 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -116.74 96.71 49.14 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.184 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.49 1.323 0 O-C-N 123.346 1.182 . . . . 0.0 110.297 178.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.85 175.37 50.29 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.8 133.07 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -121.84 144.62 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.5 117.3 8.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.094 -0.379 . . . . 0.0 110.597 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 p -131.06 154.24 48.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.105 -0.372 . . . . 0.0 110.092 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.51 133.86 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 p -147.49 158.65 44.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.117 -0.364 . . . . 0.0 110.196 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -140.43 95.66 8.07 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 122.17 -0.331 . . . . 0.0 110.213 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.357 0 O-C-N 123.32 1.168 . . . . 0.0 110.295 178.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.67 131.81 6.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.55 138.21 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -108.23 119.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.7 ptp -87.41 117.76 26.4 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.472 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p -99.02 144.6 27.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.016 -0.428 . . . . 0.0 110.122 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t -95.95 148.88 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -145.21 158.09 43.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.082 -0.386 . . . . 0.0 110.207 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -129.25 97.43 25.75 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.116 -0.365 . . . . 0.0 110.238 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 O-C-N 123.291 1.153 . . . . 0.0 110.306 178.196 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 120.687 0.279 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.7 -168.83 27.97 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.5 145.71 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.4 mt -92.59 123.46 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.3 ptm -86.99 115.13 24.17 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.017 0.437 . . . . 0.0 110.557 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -112.94 158.24 20.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.948 -0.47 . . . . 0.0 110.151 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.75 136.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -148.3 -52.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 122.144 -0.347 . . . . 0.0 110.095 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -131.07 92.68 32.66 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 122.095 -0.378 . . . . 0.0 110.094 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 O-C-N 123.354 1.186 . . . . 0.0 110.248 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.3 173.62 31.26 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.52 136.79 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.0 138.76 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 ptp -145.57 119.79 9.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.083 -0.386 . . . . 0.0 110.415 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -112.88 158.89 19.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.114 -0.366 . . . . 0.0 110.304 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.01 141.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -147.04 152.89 39.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 122.102 -0.374 . . . . 0.0 110.222 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -132.35 92.08 29.33 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.49 1.315 0 O-C-N 123.367 1.193 . . . . 0.0 110.306 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.42 -40.23 2.58 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.78 130.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.983 -0.716 . . . . 0.0 109.283 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.17 131.91 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.6 ptm -86.26 115.9 24.1 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.994 0.426 . . . . 0.0 110.341 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -120.16 155.04 33.89 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.945 -0.472 . . . . 0.0 110.219 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t -93.67 138.51 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 p -148.37 -47.44 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.252 173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -101.43 158.87 30.96 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.231 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.412 1.217 . . . . 0.0 110.716 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.47 -141.09 9.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.76 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 122.087 -0.655 . . . . 0.0 109.247 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.19 138.22 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -85.13 112.99 21.18 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.13 0.491 . . . . 0.0 110.349 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.6 p -91.88 164.1 13.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.968 -0.457 . . . . 0.0 110.188 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -93.67 137.51 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -119.01 96.66 50.34 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.114 -0.366 . . . . 0.0 110.211 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.317 0 O-C-N 123.321 1.169 . . . . 0.0 110.275 177.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.58 -139.94 9.82 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.97 142.44 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.056 -0.673 . . . . 0.0 109.249 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.37 132.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -86.17 114.58 23.12 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.127 0.489 . . . . 0.0 110.558 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p -97.76 162.05 13.46 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.902 -0.499 . . . . 0.0 110.07 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.23 144.23 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.6 p -146.61 164.04 33.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 122.125 -0.36 . . . . 0.0 110.291 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -122.47 91.39 49.36 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 122.055 -0.403 . . . . 0.0 110.083 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.491 1.326 0 O-C-N 123.427 1.225 . . . . 0.0 110.283 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.69 70.3 1.11 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.41 139.24 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.909 -0.76 . . . . 0.0 109.029 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -111.22 122.46 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -88.0 114.87 25.04 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.387 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -105.88 155.61 19.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.992 -0.442 . . . . 0.0 110.266 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.1 139.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.2 p -146.48 160.51 42.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 172.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.07 96.25 29.24 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 122.09 -0.382 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.363 0 O-C-N 123.349 1.184 . . . . 0.0 110.268 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.23 -40.19 2.6 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.47 132.88 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.945 -0.738 . . . . 0.0 109.257 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.4 mt -118.33 138.78 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -85.49 114.95 22.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.324 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -118.98 154.67 32.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.982 -0.449 . . . . 0.0 110.275 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -92.78 139.26 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.23 173.57 12.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 122.203 -0.31 . . . . 0.0 110.303 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -103.31 157.65 33.39 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.49 1.3 0 O-C-N 123.435 1.229 . . . . 0.0 110.299 179.857 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 N--CA 1.502 2.137 0 CA-C-O 120.689 0.28 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.55 153.14 9.41 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.81 128.0 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.27 133.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -145.6 119.54 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.072 -0.393 . . . . 0.0 110.503 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -108.96 151.23 26.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.112 -0.367 . . . . 0.0 110.139 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.45 135.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 p -147.47 163.1 37.59 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.151 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -128.71 95.73 31.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 122.13 -0.356 . . . . 0.0 110.155 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.492 1.392 0 O-C-N 123.31 1.163 . . . . 0.0 110.226 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.691 0.282 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.82 68.23 3.57 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.32 138.07 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.075 -0.662 . . . . 0.0 109.252 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.08 118.05 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -88.72 112.85 23.64 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.042 0.449 . . . . 0.0 110.759 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -104.56 151.05 24.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.946 -0.471 . . . . 0.0 110.063 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -92.58 125.04 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.16 174.8 11.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 172.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -106.35 158.38 32.75 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.267 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.406 1.214 . . . . 0.0 110.741 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 120.857 0.361 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.16 178.98 25.57 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t 51.16 85.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 O-C-N 121.766 -0.844 . . . . 0.0 110.952 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.31 138.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.5 ptp -90.56 137.57 32.25 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.86 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p -110.44 152.25 26.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 110.339 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.12 136.73 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.1 p -147.78 97.36 2.81 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.827 0.346 . . . . 0.0 110.108 173.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -142.47 96.39 6.32 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 122.037 -0.414 . . . . 0.0 110.197 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 O-C-N 123.302 1.159 . . . . 0.0 110.66 178.7 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.76 163.39 45.88 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.3 t -146.74 135.57 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -114.69 113.69 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 ptp -87.9 116.43 26.06 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -125.13 141.0 52.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.888 -0.507 . . . . 0.0 110.272 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -95.49 141.14 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.9 p -147.68 120.2 8.52 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.247 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -151.2 97.2 3.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 122.133 -0.355 . . . . 0.0 110.166 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.494 1.508 0 O-C-N 123.228 1.12 . . . . 0.0 110.652 178.56 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.733 0.301 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.11 70.16 0.32 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.5 t -146.72 151.06 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -89.01 145.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.51 120.46 10.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.171 -0.331 . . . . 0.0 110.431 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p -99.26 152.75 19.57 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.2 142.91 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.6 p -146.12 162.49 37.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 122.163 -0.336 . . . . 0.0 110.149 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -122.54 96.39 45.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 122.126 -0.359 . . . . 0.0 110.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.228 1.12 . . . . 0.0 110.613 178.1 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.36 129.97 6.1 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -178.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.28 129.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.084 -0.657 . . . . 0.0 109.384 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.75 113.95 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -86.82 114.2 23.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.165 0.507 . . . . 0.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p -119.27 142.32 48.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.9 -0.5 . . . . 0.0 110.142 174.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -94.73 132.43 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.07 32.91 0.82 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.752 0.311 . . . . 0.0 110.404 173.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -121.55 96.34 47.62 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.93 -0.481 . . . . 0.0 110.231 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.349 0 O-C-N 123.375 1.197 . . . . 0.0 110.26 178.615 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 . . . . . 0 N--CA 1.508 2.468 0 CA-C-O 120.634 0.254 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.35 178.7 46.98 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.4 136.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -114.78 151.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.6 ptp -145.42 119.31 9.31 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.809 0.337 . . . . 0.0 110.482 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -128.82 154.09 46.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.163 -0.336 . . . . 0.0 110.233 178.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.41 140.68 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -146.87 168.19 22.05 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.289 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -116.9 93.08 40.72 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 122.051 -0.406 . . . . 0.0 110.346 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 O-C-N 123.229 1.12 . . . . 0.0 110.308 179.366 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.175 -0.306 . . . . 0.42 110.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.15 110.031 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 1.97 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 0.33 110.328 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.15 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.4 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 0.33 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.3 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 2.68 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 0.56 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 0.66 110.369 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.52 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.509 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.46 112.791 -173.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.592 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.53 111.186 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 0.79 110.707 -171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 0.43 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 0.37 109.94 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.74 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 0.42 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.25 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 33' ' ' ILE . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 0.51 111.587 -167.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.25 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 1.91 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 0.19 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 0.17 110.43 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.42 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 0.26 111.469 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 0.19 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 0.22 110.281 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 0.4 109.106 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.08 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.574 HD12 HG11 ' A' ' 57' ' ' VAL . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 0.77 109.469 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 1.42 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.6 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 2.67 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.42 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.574 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 0.36 109.72 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 1.61 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.46 110.185 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 1.47 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 0.15 109.062 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 -173.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.78 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 0.12 109.917 172.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.28 110.091 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.623 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.18 110.257 -16.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.627 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.24 109.835 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.38 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 0.15 110.435 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 2.69 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 0.24 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.65 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 3.49 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.24 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 1.41 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 0.42 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 0.29 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 0.43 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 0.46 109.426 179.216 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' LYS . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD12 HG22 ' A' ' 33' ' ' ILE . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 HG11 ' A' ' 57' ' ' VAL . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.611 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' HD12 ' A' ' 20' ' ' LEU . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.656 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 120.784 0.326 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 42' ' ' VAL . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 29' ' ' PHE . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 33' ' ' ILE . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.499 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 33' ' ' ILE . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' CB ' HD12 ' A' ' 20' ' ' LEU . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 50' ' ' ILE . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.648 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.61 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.807 0.337 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 58' ' ' LYS . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 33' ' ' ILE . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.572 HD12 ' CD2' ' A' ' 59' ' ' PHE . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.645 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.645 HG11 HD12 ' A' ' 52' ' ' ILE . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.572 ' CD2' HD12 ' A' ' 50' ' ' ILE . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 44' ' ' THR . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 75' ' ' THR . 79.7 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 61' ' ' VAL . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 29' ' ' PHE . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.503 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.593 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 33' ' ' ILE . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 59' ' ' PHE . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.69 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 13' ' ' SER . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.824 0.345 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 69' ' ' LEU . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 58' ' ' LYS . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' CE2' ' A' ' 29' ' ' PHE . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 33' ' ' ILE . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 15' ' ' LEU . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 ' CG2' ' A' ' 50' ' ' ILE . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' A' ' 20' ' ' LEU . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.672 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' HG23 ' A' ' 75' ' ' THR . 26.8 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 61' ' ' VAL . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' LYS . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 29' ' ' PHE . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.623 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' VAL . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 33' ' ' ILE . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 47' ' ' VAL . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.617 ' O ' HD23 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 13' ' ' SER . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 71' ' ' VAL . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 33' ' ' ILE . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.448 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD2' HD12 ' A' ' 50' ' ' ILE . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.6 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 15' ' ' LEU . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 75' ' ' THR . 97.2 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 42' ' ' VAL . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 61' ' ' VAL . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 37' ' ' LEU . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 33' ' ' ILE . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 52' ' ' ILE . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.569 HD12 HG11 ' A' ' 57' ' ' VAL . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG11 HD12 ' A' ' 52' ' ' ILE . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 50' ' ' ILE . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.651 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' OG ' ' A' ' 13' ' ' SER . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' OG ' HG23 ' A' ' 75' ' ' THR . 88.0 p . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 120.837 0.351 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 61' ' ' VAL . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 58' ' ' LYS . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 HG22 ' A' ' 33' ' ' ILE . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 57' ' ' VAL . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' HD12 ' A' ' 20' ' ' LEU . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 44' ' ' THR . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' A' ' 65' ' ' TYR . 8.2 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.727 ' O ' HD23 ' A' ' 69' ' ' LEU . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.544 HG23 ' OG ' ' A' ' 13' ' ' SER . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.727 0.299 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 HD11 ' A' ' 17' ' ' LEU . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 15' ' ' LEU . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 58' ' ' LYS . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 29' ' ' PHE . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.609 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 HG11 ' A' ' 57' ' ' VAL . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.545 ' HB3' HD12 ' A' ' 20' ' ' LEU . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 50' ' ' ILE . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 47' ' ' VAL . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' THR . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.64 ' O ' HD23 ' A' ' 69' ' ' LEU . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 95.6 p . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.776 0.322 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 61' ' ' VAL . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 58' ' ' LYS . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.523 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.523 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 33' ' ' ILE . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.684 HD12 HG11 ' A' ' 57' ' ' VAL . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB3' HD12 ' A' ' 20' ' ' LEU . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 44' ' ' THR . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.632 ' O ' HD23 ' A' ' 69' ' ' LEU . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 17' ' ' LEU . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 61' ' ' VAL . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 29' ' ' PHE . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.5 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 32' ' ' VAL . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 33' ' ' ILE . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.599 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.592 HD12 HG11 ' A' ' 57' ' ' VAL . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG11 HD12 ' A' ' 52' ' ' ILE . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CB ' HD12 ' A' ' 20' ' ' LEU . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.511 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.695 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 80.2 p . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.82 0.343 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 58' ' ' LYS . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 33' ' ' ILE . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 62' ' ' VAL . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 44' ' ' THR . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.765 0.317 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 16' ' ' LYS . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' N ' HD23 ' A' ' 15' ' ' LEU . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 35' ' ' ILE . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' VAL . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 33' ' ' ILE . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 57' ' ' VAL . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.593 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 42' ' ' VAL . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.605 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 32' ' ' VAL . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.666 HD12 HG11 ' A' ' 57' ' ' VAL . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.618 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.623 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 42' ' ' VAL . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 61' ' ' VAL . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD22 ' CE2' ' A' ' 29' ' ' PHE . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.758 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 33' ' ' ILE . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 15' ' ' LEU . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' CB ' HD12 ' A' ' 20' ' ' LEU . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD12 ' A' ' 50' ' ' ILE . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.749 0.309 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.602 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 33' ' ' ILE . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' HD12 ' A' ' 20' ' ' LEU . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.503 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.737 0.304 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 15' ' ' LEU . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.52 HD12 ' HB3' ' A' ' 58' ' ' LYS . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 HG22 ' A' ' 33' ' ' ILE . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD13 ' A' ' 15' ' ' LEU . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 57' ' ' VAL . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 20' ' ' LEU . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 50' ' ' ILE . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' THR . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 42' ' ' VAL . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 29' ' ' PHE . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 HG22 HD12 ' A' ' 37' ' ' LEU . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 32' ' ' VAL . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 33' ' ' ILE . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 15' ' ' LEU . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' A' ' 59' ' ' PHE . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 57' ' ' VAL . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 52' ' ' ILE . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 52' ' ' ILE . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.674 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.69 HD13 HG21 ' A' ' 42' ' ' VAL . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 15' ' ' LEU . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' ASP . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.693 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.693 HD12 HG22 ' A' ' 33' ' ' ILE . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG21 HD13 ' A' ' 15' ' ' LEU . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 52' ' ' ILE . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 50' ' ' ILE . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 50' ' ' ILE . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.658 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.801 0.334 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 17' ' ' LEU . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 15' ' ' LEU . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 58' ' ' LYS . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 29' ' ' PHE . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 37' ' ' LEU . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 33' ' ' ILE . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.625 HD12 HG22 ' A' ' 33' ' ' ILE . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.629 HD12 HG11 ' A' ' 57' ' ' VAL . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 52' ' ' ILE . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG11 HD12 ' A' ' 52' ' ' ILE . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' CB ' HD12 ' A' ' 20' ' ' LEU . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 44' ' ' THR . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.036 -0.357 . . . . 6.58 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.51 168.34 38.1 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.529 -1.428 . . . . 3.44 109.529 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.83 137.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.191 -0.67 . . . . 2.82 109.191 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -107.83 132.67 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.233 -0.655 . . . . 2.73 109.233 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptm -145.6 120.77 10.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.217 -0.302 . . . . 2.19 110.329 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p -100.43 155.26 17.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.138 -0.351 . . . . 0.42 110.175 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.15 110.031 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 1.97 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 0.33 110.328 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.15 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.4 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 0.33 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.3 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 2.68 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 0.56 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 0.66 110.369 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.52 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.46 112.791 -173.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.592 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.53 111.186 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 0.79 110.707 -171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 0.43 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 0.37 109.94 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.74 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 0.42 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.25 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 33' ' ' ILE . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 0.51 111.587 -167.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.25 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 1.91 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 0.19 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 0.17 110.43 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.42 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 0.26 111.469 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 0.19 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 0.22 110.281 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 0.4 109.106 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.08 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.574 HD12 HG11 ' A' ' 57' ' ' VAL . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 0.77 109.469 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 1.42 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.6 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 2.67 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.42 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.574 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 0.36 109.72 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 1.61 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.46 110.185 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 1.47 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 0.15 109.062 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 -173.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.78 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 0.12 109.917 172.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.28 110.091 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.623 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.18 110.257 -16.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.627 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.24 109.835 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.38 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 0.15 110.435 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 2.69 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 0.24 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.65 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 3.49 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.24 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 1.41 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 0.42 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 0.29 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 0.43 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.77 137.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 0.46 109.426 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.47 164.99 31.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.139 -0.351 . . . . 1.34 110.242 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -99.71 154.94 37.0 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.328 -0.368 . . . . 4.7 110.189 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 O-C-N 123.476 1.251 . . . . 4.32 110.219 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 120.73 0.3 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.02 -140.09 3.17 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.95 130.77 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.1 mt -119.31 124.49 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -88.05 117.76 27.15 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.349 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p -76.89 148.34 36.5 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.988 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' LYS . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD12 HG22 ' A' ' 33' ' ' ILE . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 HG11 ' A' ' 57' ' ' VAL . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.611 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' HD12 ' A' ' 20' ' ' LEU . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.656 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t -94.23 136.19 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.37 162.64 38.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.159 -0.338 . . . . 0.0 110.224 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -130.79 92.18 34.99 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.08 -0.388 . . . . 0.0 110.278 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.148 1.078 . . . . 0.0 110.693 179.801 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -140.01 30.57 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 131.47 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.033 -0.686 . . . . 0.0 109.258 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.8 mm -116.92 137.81 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -86.66 111.5 20.72 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.063 0.458 . . . . 0.0 110.378 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p -101.57 152.05 21.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.917 -0.489 . . . . 0.0 110.243 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 42' ' ' VAL . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 29' ' ' PHE . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 33' ' ' ILE . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.499 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 33' ' ' ILE . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' CB ' HD12 ' A' ' 20' ' ' LEU . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 50' ' ' ILE . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.648 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.61 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t -94.91 143.61 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.0 p -148.02 -49.62 0.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.205 -0.309 . . . . 0.0 110.293 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -105.37 108.31 61.12 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.564 0 O-C-N 123.13 1.069 . . . . 0.0 110.736 178.804 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.68 -142.92 1.12 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.32 142.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -95.3 116.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptp -87.31 118.07 26.49 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.563 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p -105.37 145.64 30.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.955 -0.466 . . . . 0.0 110.158 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 58' ' ' LYS . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 33' ' ' ILE . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.572 HD12 ' CD2' ' A' ' 59' ' ' PHE . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.645 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.645 HG11 HD12 ' A' ' 52' ' ' ILE . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.572 ' CD2' HD12 ' A' ' 50' ' ' ILE . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 44' ' ' THR . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t -93.59 135.0 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -147.46 167.82 23.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.187 -0.32 . . . . 0.0 110.206 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -105.2 155.18 38.19 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.295 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 O-C-N 123.569 1.3 . . . . 0.0 110.261 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -158.17 1.49 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.17 133.78 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.84 129.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.8 ptp -86.07 114.18 22.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.108 0.48 . . . . 0.0 110.598 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 75' ' ' THR . 79.7 p -99.41 154.17 18.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.008 -0.432 . . . . 0.0 109.975 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 61' ' ' VAL . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 29' ' ' PHE . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.503 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.593 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 33' ' ' ILE . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 59' ' ' PHE . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.69 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 13' ' ' SER . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.01 138.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.1 p -147.6 169.03 20.49 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.23 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -112.37 97.53 40.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 122.057 -0.402 . . . . 0.0 110.188 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.474 0 O-C-N 123.239 1.126 . . . . 0.0 110.67 179.195 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 70.09 2.51 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.2 138.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -106.28 124.46 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -87.62 116.58 25.84 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p -108.48 148.9 29.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.034 -0.416 . . . . 0.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 69' ' ' LEU . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 58' ' ' LYS . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' CE2' ' A' ' 29' ' ' PHE . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 33' ' ' ILE . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 15' ' ' LEU . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 ' CG2' ' A' ' 50' ' ' ILE . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' A' ' 20' ' ' LEU . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.672 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t -93.76 134.82 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -147.71 33.22 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.788 0.328 . . . . 0.0 110.333 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -116.74 96.71 49.14 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.184 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.49 1.323 0 O-C-N 123.346 1.182 . . . . 0.0 110.297 178.412 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.85 175.37 50.29 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.8 133.07 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -121.84 144.62 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.5 117.3 8.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.094 -0.379 . . . . 0.0 110.597 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' HG23 ' A' ' 75' ' ' THR . 26.8 p -131.06 154.24 48.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.105 -0.372 . . . . 0.0 110.092 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 61' ' ' VAL . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' LYS . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 29' ' ' PHE . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.623 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' VAL . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 33' ' ' ILE . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 47' ' ' VAL . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.617 ' O ' HD23 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 13' ' ' SER . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.51 133.86 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 p -147.49 158.65 44.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.117 -0.364 . . . . 0.0 110.196 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -140.43 95.66 8.07 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 122.17 -0.331 . . . . 0.0 110.213 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.357 0 O-C-N 123.32 1.168 . . . . 0.0 110.295 178.936 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.67 131.81 6.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.55 138.21 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -108.23 119.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.7 ptp -87.41 117.76 26.4 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.472 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p -99.02 144.6 27.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.016 -0.428 . . . . 0.0 110.122 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 71' ' ' VAL . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 33' ' ' ILE . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.448 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD2' HD12 ' A' ' 50' ' ' ILE . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.6 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 15' ' ' LEU . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t -95.95 148.88 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -145.21 158.09 43.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.082 -0.386 . . . . 0.0 110.207 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -129.25 97.43 25.75 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.116 -0.365 . . . . 0.0 110.238 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 O-C-N 123.291 1.153 . . . . 0.0 110.306 178.196 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 120.687 0.279 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.7 -168.83 27.97 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.5 145.71 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.4 mt -92.59 123.46 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.3 ptm -86.99 115.13 24.17 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.017 0.437 . . . . 0.0 110.557 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 75' ' ' THR . 97.2 p -112.94 158.24 20.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.948 -0.47 . . . . 0.0 110.151 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 42' ' ' VAL . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 61' ' ' VAL . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 37' ' ' LEU . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 33' ' ' ILE . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 52' ' ' ILE . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.569 HD12 HG11 ' A' ' 57' ' ' VAL . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG11 HD12 ' A' ' 52' ' ' ILE . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 50' ' ' ILE . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.651 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' OG ' ' A' ' 13' ' ' SER . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.75 136.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -148.3 -52.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 122.144 -0.347 . . . . 0.0 110.095 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -131.07 92.68 32.66 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 122.095 -0.378 . . . . 0.0 110.094 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 O-C-N 123.354 1.186 . . . . 0.0 110.248 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.3 173.62 31.26 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.52 136.79 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.0 138.76 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 ptp -145.57 119.79 9.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.083 -0.386 . . . . 0.0 110.415 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' OG ' HG23 ' A' ' 75' ' ' THR . 88.0 p -112.88 158.89 19.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.114 -0.366 . . . . 0.0 110.304 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 61' ' ' VAL . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 58' ' ' LYS . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 HG22 ' A' ' 33' ' ' ILE . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 57' ' ' VAL . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' HD12 ' A' ' 20' ' ' LEU . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 44' ' ' THR . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' A' ' 65' ' ' TYR . 8.2 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.727 ' O ' HD23 ' A' ' 69' ' ' LEU . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.544 HG23 ' OG ' ' A' ' 13' ' ' SER . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.01 141.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -147.04 152.89 39.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 122.102 -0.374 . . . . 0.0 110.222 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -132.35 92.08 29.33 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.49 1.315 0 O-C-N 123.367 1.193 . . . . 0.0 110.306 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.42 -40.23 2.58 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.78 130.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.983 -0.716 . . . . 0.0 109.283 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.17 131.91 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.6 ptm -86.26 115.9 24.1 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.994 0.426 . . . . 0.0 110.341 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -120.16 155.04 33.89 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.945 -0.472 . . . . 0.0 110.219 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 HD11 ' A' ' 17' ' ' LEU . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 15' ' ' LEU . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 58' ' ' LYS . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 29' ' ' PHE . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.609 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 HG11 ' A' ' 57' ' ' VAL . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.545 ' HB3' HD12 ' A' ' 20' ' ' LEU . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 50' ' ' ILE . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 47' ' ' VAL . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' THR . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.64 ' O ' HD23 ' A' ' 69' ' ' LEU . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t -93.67 138.51 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 p -148.37 -47.44 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.252 173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -101.43 158.87 30.96 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.231 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.412 1.217 . . . . 0.0 110.716 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.47 -141.09 9.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.76 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 122.087 -0.655 . . . . 0.0 109.247 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.19 138.22 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -85.13 112.99 21.18 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.13 0.491 . . . . 0.0 110.349 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 95.6 p -91.88 164.1 13.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.968 -0.457 . . . . 0.0 110.188 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 61' ' ' VAL . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 58' ' ' LYS . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.523 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.523 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 33' ' ' ILE . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.684 HD12 HG11 ' A' ' 57' ' ' VAL . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB3' HD12 ' A' ' 20' ' ' LEU . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 44' ' ' THR . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.632 ' O ' HD23 ' A' ' 69' ' ' LEU . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -93.67 137.51 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -119.01 96.66 50.34 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.114 -0.366 . . . . 0.0 110.211 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.317 0 O-C-N 123.321 1.169 . . . . 0.0 110.275 177.799 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.58 -139.94 9.82 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.97 142.44 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.056 -0.673 . . . . 0.0 109.249 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.37 132.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -86.17 114.58 23.12 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.127 0.489 . . . . 0.0 110.558 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p -97.76 162.05 13.46 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.902 -0.499 . . . . 0.0 110.07 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 17' ' ' LEU . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 61' ' ' VAL . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 29' ' ' PHE . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.5 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 32' ' ' VAL . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 33' ' ' ILE . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.599 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.592 HD12 HG11 ' A' ' 57' ' ' VAL . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG11 HD12 ' A' ' 52' ' ' ILE . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CB ' HD12 ' A' ' 20' ' ' LEU . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.511 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.23 144.23 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.6 p -146.61 164.04 33.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 122.125 -0.36 . . . . 0.0 110.291 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -122.47 91.39 49.36 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 122.055 -0.403 . . . . 0.0 110.083 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.491 1.326 0 O-C-N 123.427 1.225 . . . . 0.0 110.283 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.69 70.3 1.11 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.41 139.24 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.909 -0.76 . . . . 0.0 109.029 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -111.22 122.46 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -88.0 114.87 25.04 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.387 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 80.2 p -105.88 155.61 19.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.992 -0.442 . . . . 0.0 110.266 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 58' ' ' LYS . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 33' ' ' ILE . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 62' ' ' VAL . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 44' ' ' THR . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.1 139.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.2 p -146.48 160.51 42.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 172.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.07 96.25 29.24 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 122.09 -0.382 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.363 0 O-C-N 123.349 1.184 . . . . 0.0 110.268 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.23 -40.19 2.6 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.47 132.88 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.945 -0.738 . . . . 0.0 109.257 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.4 mt -118.33 138.78 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -85.49 114.95 22.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.324 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -118.98 154.67 32.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.982 -0.449 . . . . 0.0 110.275 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 16' ' ' LYS . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' N ' HD23 ' A' ' 15' ' ' LEU . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 35' ' ' ILE . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' VAL . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 33' ' ' ILE . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 57' ' ' VAL . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.593 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -92.78 139.26 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.23 173.57 12.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 122.203 -0.31 . . . . 0.0 110.303 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -103.31 157.65 33.39 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.49 1.3 0 O-C-N 123.435 1.229 . . . . 0.0 110.299 179.857 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 N--CA 1.502 2.137 0 CA-C-O 120.689 0.28 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.55 153.14 9.41 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.81 128.0 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.27 133.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -145.6 119.54 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.072 -0.393 . . . . 0.0 110.503 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -108.96 151.23 26.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.112 -0.367 . . . . 0.0 110.139 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 42' ' ' VAL . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.605 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 32' ' ' VAL . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.666 HD12 HG11 ' A' ' 57' ' ' VAL . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.618 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.623 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.45 135.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 p -147.47 163.1 37.59 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.151 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -128.71 95.73 31.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 122.13 -0.356 . . . . 0.0 110.155 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.492 1.392 0 O-C-N 123.31 1.163 . . . . 0.0 110.226 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.691 0.282 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.82 68.23 3.57 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.32 138.07 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.075 -0.662 . . . . 0.0 109.252 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.08 118.05 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -88.72 112.85 23.64 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.042 0.449 . . . . 0.0 110.759 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -104.56 151.05 24.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.946 -0.471 . . . . 0.0 110.063 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 42' ' ' VAL . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 61' ' ' VAL . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD22 ' CE2' ' A' ' 29' ' ' PHE . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.758 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 33' ' ' ILE . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 15' ' ' LEU . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' CB ' HD12 ' A' ' 20' ' ' LEU . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD12 ' A' ' 50' ' ' ILE . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -92.58 125.04 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.16 174.8 11.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 172.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -106.35 158.38 32.75 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.267 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.406 1.214 . . . . 0.0 110.741 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 120.857 0.361 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.16 178.98 25.57 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t 51.16 85.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 O-C-N 121.766 -0.844 . . . . 0.0 110.952 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.31 138.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.5 ptp -90.56 137.57 32.25 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.86 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p -110.44 152.25 26.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 110.339 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.602 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 33' ' ' ILE . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' HD12 ' A' ' 20' ' ' LEU . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.503 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.12 136.73 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.1 p -147.78 97.36 2.81 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.827 0.346 . . . . 0.0 110.108 173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -142.47 96.39 6.32 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 122.037 -0.414 . . . . 0.0 110.197 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 O-C-N 123.302 1.159 . . . . 0.0 110.66 178.7 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.76 163.39 45.88 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.3 t -146.74 135.57 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -114.69 113.69 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 ptp -87.9 116.43 26.06 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -125.13 141.0 52.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.888 -0.507 . . . . 0.0 110.272 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 15' ' ' LEU . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.52 HD12 ' HB3' ' A' ' 58' ' ' LYS . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 HG22 ' A' ' 33' ' ' ILE . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD13 ' A' ' 15' ' ' LEU . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 57' ' ' VAL . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 20' ' ' LEU . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 50' ' ' ILE . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' THR . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -95.49 141.14 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.9 p -147.68 120.2 8.52 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.247 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -151.2 97.2 3.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 122.133 -0.355 . . . . 0.0 110.166 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.494 1.508 0 O-C-N 123.228 1.12 . . . . 0.0 110.652 178.56 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.733 0.301 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.11 70.16 0.32 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.5 t -146.72 151.06 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -89.01 145.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.51 120.46 10.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.171 -0.331 . . . . 0.0 110.431 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p -99.26 152.75 19.57 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 42' ' ' VAL . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 29' ' ' PHE . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 HG22 HD12 ' A' ' 37' ' ' LEU . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 32' ' ' VAL . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 33' ' ' ILE . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 15' ' ' LEU . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' A' ' 59' ' ' PHE . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 57' ' ' VAL . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 52' ' ' ILE . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 52' ' ' ILE . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.674 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.2 142.91 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.6 p -146.12 162.49 37.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 122.163 -0.336 . . . . 0.0 110.149 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -122.54 96.39 45.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 122.126 -0.359 . . . . 0.0 110.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.228 1.12 . . . . 0.0 110.613 178.1 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.36 129.97 6.1 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -178.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.28 129.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.084 -0.657 . . . . 0.0 109.384 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.75 113.95 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -86.82 114.2 23.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.165 0.507 . . . . 0.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p -119.27 142.32 48.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.9 -0.5 . . . . 0.0 110.142 174.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.69 HD13 HG21 ' A' ' 42' ' ' VAL . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 15' ' ' LEU . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' ASP . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.693 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.693 HD12 HG22 ' A' ' 33' ' ' ILE . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG21 HD13 ' A' ' 15' ' ' LEU . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 52' ' ' ILE . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 50' ' ' ILE . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 50' ' ' ILE . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.658 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -94.73 132.43 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.07 32.91 0.82 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.752 0.311 . . . . 0.0 110.404 173.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -121.55 96.34 47.62 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.93 -0.481 . . . . 0.0 110.231 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.349 0 O-C-N 123.375 1.197 . . . . 0.0 110.26 178.615 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 . . . . . 0 N--CA 1.508 2.468 0 CA-C-O 120.634 0.254 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.35 178.7 46.98 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.4 136.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -114.78 151.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.6 ptp -145.42 119.31 9.31 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.809 0.337 . . . . 0.0 110.482 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -128.82 154.09 46.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.163 -0.336 . . . . 0.0 110.233 178.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 17' ' ' LEU . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 15' ' ' LEU . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 58' ' ' LYS . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 29' ' ' PHE . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 37' ' ' LEU . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 33' ' ' ILE . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.625 HD12 HG22 ' A' ' 33' ' ' ILE . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.629 HD12 HG11 ' A' ' 57' ' ' VAL . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 52' ' ' ILE . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG11 HD12 ' A' ' 52' ' ' ILE . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' CB ' HD12 ' A' ' 20' ' ' LEU . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 44' ' ' THR . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.41 140.68 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -146.87 168.19 22.05 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.289 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -116.9 93.08 40.72 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 122.051 -0.406 . . . . 0.0 110.346 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 O-C-N 123.229 1.12 . . . . 0.0 110.308 179.366 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.175 -0.306 . . . . 0.42 110.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.15 110.031 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 1.97 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 0.33 110.328 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.15 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.4 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 0.33 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.3 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 2.68 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 0.56 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 0.66 110.369 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.52 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.509 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.46 112.791 -173.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.592 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.53 111.186 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 0.79 110.707 -171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 0.43 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 0.37 109.94 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.74 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 0.42 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.25 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 33' ' ' ILE . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 0.51 111.587 -167.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.25 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 1.91 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 0.19 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 0.17 110.43 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.42 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 0.26 111.469 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 0.19 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 0.22 110.281 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 0.4 109.106 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.08 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.574 HD12 HG11 ' A' ' 57' ' ' VAL . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 0.77 109.469 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 1.42 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.6 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 2.67 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.42 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.574 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 0.36 109.72 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 1.61 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.46 110.185 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 1.47 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 0.15 109.062 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 -173.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.78 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 0.12 109.917 172.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.28 110.091 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.623 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.18 110.257 -16.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.627 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.24 109.835 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.38 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 0.15 110.435 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 2.69 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 0.24 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.65 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 3.49 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.24 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 1.41 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 0.42 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 0.29 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 0.43 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 0.46 109.426 179.216 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' LYS . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD12 HG22 ' A' ' 33' ' ' ILE . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 HG11 ' A' ' 57' ' ' VAL . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.611 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' HD12 ' A' ' 20' ' ' LEU . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.656 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 120.784 0.326 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 42' ' ' VAL . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 29' ' ' PHE . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 33' ' ' ILE . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.499 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 33' ' ' ILE . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' CB ' HD12 ' A' ' 20' ' ' LEU . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 50' ' ' ILE . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.648 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.61 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.807 0.337 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 58' ' ' LYS . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 33' ' ' ILE . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.572 HD12 ' CD2' ' A' ' 59' ' ' PHE . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.645 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.645 HG11 HD12 ' A' ' 52' ' ' ILE . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.572 ' CD2' HD12 ' A' ' 50' ' ' ILE . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 44' ' ' THR . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 75' ' ' THR . 79.7 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 61' ' ' VAL . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 29' ' ' PHE . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.503 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.593 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 33' ' ' ILE . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 59' ' ' PHE . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.69 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 13' ' ' SER . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.824 0.345 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 69' ' ' LEU . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 58' ' ' LYS . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' CE2' ' A' ' 29' ' ' PHE . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 33' ' ' ILE . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 15' ' ' LEU . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 ' CG2' ' A' ' 50' ' ' ILE . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' A' ' 20' ' ' LEU . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.672 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' HG23 ' A' ' 75' ' ' THR . 26.8 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 61' ' ' VAL . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' LYS . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 29' ' ' PHE . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.623 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' VAL . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 33' ' ' ILE . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 47' ' ' VAL . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.617 ' O ' HD23 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 13' ' ' SER . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 71' ' ' VAL . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 33' ' ' ILE . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.448 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD2' HD12 ' A' ' 50' ' ' ILE . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.6 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 15' ' ' LEU . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 75' ' ' THR . 97.2 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 42' ' ' VAL . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 61' ' ' VAL . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 37' ' ' LEU . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 33' ' ' ILE . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 52' ' ' ILE . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.569 HD12 HG11 ' A' ' 57' ' ' VAL . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG11 HD12 ' A' ' 52' ' ' ILE . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 50' ' ' ILE . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.651 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' OG ' ' A' ' 13' ' ' SER . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.544 ' OG ' HG23 ' A' ' 75' ' ' THR . 88.0 p . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 120.837 0.351 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 61' ' ' VAL . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 58' ' ' LYS . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 HG22 ' A' ' 33' ' ' ILE . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 57' ' ' VAL . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' HD12 ' A' ' 20' ' ' LEU . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 44' ' ' THR . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.727 ' O ' HD23 ' A' ' 69' ' ' LEU . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.544 HG23 ' OG ' ' A' ' 13' ' ' SER . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.727 0.299 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 HD11 ' A' ' 17' ' ' LEU . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 15' ' ' LEU . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 58' ' ' LYS . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 29' ' ' PHE . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.609 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 HG11 ' A' ' 57' ' ' VAL . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.545 ' HB3' HD12 ' A' ' 20' ' ' LEU . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 50' ' ' ILE . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 47' ' ' VAL . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' THR . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.64 ' O ' HD23 ' A' ' 69' ' ' LEU . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 95.6 p . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.776 0.322 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 61' ' ' VAL . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 58' ' ' LYS . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.523 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.523 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 33' ' ' ILE . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.684 HD12 HG11 ' A' ' 57' ' ' VAL . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB3' HD12 ' A' ' 20' ' ' LEU . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 44' ' ' THR . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.632 ' O ' HD23 ' A' ' 69' ' ' LEU . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 17' ' ' LEU . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 61' ' ' VAL . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 29' ' ' PHE . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.5 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 32' ' ' VAL . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 33' ' ' ILE . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.599 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.592 HD12 HG11 ' A' ' 57' ' ' VAL . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG11 HD12 ' A' ' 52' ' ' ILE . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CB ' HD12 ' A' ' 20' ' ' LEU . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.511 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.695 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 80.2 p . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 120.82 0.343 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 58' ' ' LYS . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 33' ' ' ILE . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 62' ' ' VAL . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 44' ' ' THR . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.765 0.317 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 16' ' ' LYS . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' N ' HD23 ' A' ' 15' ' ' LEU . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 35' ' ' ILE . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' VAL . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 33' ' ' ILE . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 57' ' ' VAL . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.593 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 42' ' ' VAL . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.605 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 32' ' ' VAL . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.666 HD12 HG11 ' A' ' 57' ' ' VAL . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.618 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.623 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 42' ' ' VAL . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 61' ' ' VAL . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD22 ' CE2' ' A' ' 29' ' ' PHE . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.758 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 33' ' ' ILE . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 15' ' ' LEU . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' CB ' HD12 ' A' ' 20' ' ' LEU . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD12 ' A' ' 50' ' ' ILE . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.749 0.309 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.602 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 33' ' ' ILE . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' HD12 ' A' ' 20' ' ' LEU . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.503 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.737 0.304 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 15' ' ' LEU . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.52 HD12 ' HB3' ' A' ' 58' ' ' LYS . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 HG22 ' A' ' 33' ' ' ILE . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD13 ' A' ' 15' ' ' LEU . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 57' ' ' VAL . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 20' ' ' LEU . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 50' ' ' ILE . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' THR . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 42' ' ' VAL . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 29' ' ' PHE . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 HG22 HD12 ' A' ' 37' ' ' LEU . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 32' ' ' VAL . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 33' ' ' ILE . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 15' ' ' LEU . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' A' ' 59' ' ' PHE . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 57' ' ' VAL . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 52' ' ' ILE . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 52' ' ' ILE . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.674 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.69 HD13 HG21 ' A' ' 42' ' ' VAL . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 15' ' ' LEU . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' ASP . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.693 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.693 HD12 HG22 ' A' ' 33' ' ' ILE . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG21 HD13 ' A' ' 15' ' ' LEU . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 52' ' ' ILE . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 50' ' ' ILE . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 50' ' ' ILE . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.658 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.801 0.334 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 17' ' ' LEU . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 15' ' ' LEU . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 58' ' ' LYS . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 29' ' ' PHE . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 37' ' ' LEU . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 33' ' ' ILE . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.625 HD12 HG22 ' A' ' 33' ' ' ILE . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.629 HD12 HG11 ' A' ' 57' ' ' VAL . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 52' ' ' ILE . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG11 HD12 ' A' ' 52' ' ' ILE . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' CB ' HD12 ' A' ' 20' ' ' LEU . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 44' ' ' THR . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.036 -0.357 . . . . 6.58 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.51 168.34 38.1 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.529 -1.428 . . . . 3.44 109.529 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.83 137.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.191 -0.67 . . . . 2.82 109.191 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -107.83 132.67 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.233 -0.655 . . . . 2.73 109.233 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptm -145.6 120.77 10.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.217 -0.302 . . . . 2.19 110.329 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.0 p -100.43 155.26 17.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.138 -0.351 . . . . 0.42 110.175 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -153.21 150.39 28.96 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.993 0.425 . . . . 1.46 110.74 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -126.37 130.27 50.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.083 -0.386 . . . . 1.15 110.031 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -104.69 131.58 51.96 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.802 -0.359 . . . . 1.97 110.328 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 33.3 mt -126.28 153.57 44.61 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.738 0.304 . . . . 0.33 110.328 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -133.48 128.71 20.27 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 119.027 -0.511 . . . . 1.15 110.029 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.85 140.35 45.94 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.167 1.088 . . . . 0.4 110.146 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -79.4 -48.67 1.48 Allowed Pre-proline 0 N--CA 1.501 2.116 0 CA-C-O 116.753 -1.594 . . . . 0.33 113.328 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.47 160.16 50.4 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.714 1.648 . . . . 0.3 110.138 167.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.39 92.74 7.62 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.891 0.377 . . . . 2.68 110.156 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.68 141.82 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.995 -0.44 . . . . 0.56 110.186 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -117.87 119.22 34.21 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.132 -0.355 . . . . 2.04 110.072 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.9 mt -93.28 144.84 28.96 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.226 -0.416 . . . . 0.66 110.369 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.68 164.49 9.4 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.203 1.107 . . . . 0.52 111.667 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.62 -9.49 24.54 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 O-C-N 123.498 1.262 . . . . 0.46 112.791 -173.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.17 -28.43 54.04 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.157 0.89 . . . . 1.21 110.688 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.592 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.7 m-85 -59.14 -44.96 92.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.618 -0.676 . . . . 0.53 111.186 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.8 -33.06 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 121.733 -0.604 . . . . 0.79 110.707 -171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.02 -42.3 73.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.11 -0.369 . . . . 1.72 110.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.78 -39.75 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.366 -0.605 . . . . 0.43 109.366 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.28 -43.44 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.89 -0.507 . . . . 0.37 109.94 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.85 -41.58 87.31 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.851 -0.53 . . . . 0.74 111.205 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.9 -42.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.931 -0.481 . . . . 0.42 109.924 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -65.24 -42.45 93.35 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.042 -0.412 . . . . 2.25 111.073 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 33' ' ' ILE . 83.5 mt -89.47 -30.45 18.27 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.904 -0.498 . . . . 0.51 111.587 -167.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.24 147.49 5.56 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 121.678 -0.639 . . . . 0.64 112.288 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.75 20.0 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.594 -1.003 . . . . 0.25 110.594 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.53 155.0 19.57 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.069 0.934 . . . . 1.91 110.121 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.9 m -99.43 147.81 24.87 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.835 0.35 . . . . 0.19 110.242 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -129.94 144.75 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.146 -0.346 . . . . 0.17 110.43 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.0 148.39 52.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.992 -0.373 . . . . 3.42 109.992 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.7 m -55.46 137.7 47.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.745 -0.597 . . . . 0.26 111.469 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.05 -17.6 57.9 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.288 -0.725 . . . . 0.19 111.288 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.05 151.55 42.68 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 118.799 1.3 . . . . 0.19 110.693 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.04 131.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.096 -0.705 . . . . 0.19 109.096 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.43 149.73 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 122.136 -0.353 . . . . 0.22 110.281 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.44 139.02 14.83 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.688 -1.365 . . . . 0.28 109.688 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.4 mt -126.21 131.73 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.106 -0.702 . . . . 0.4 109.106 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.53 120.79 31.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.071 -0.393 . . . . 1.08 110.173 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.574 HD12 HG11 ' A' ' 57' ' ' VAL . 75.7 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.469 -0.567 . . . . 0.77 109.469 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt 51.64 32.57 9.39 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.715 -0.616 . . . . 1.42 111.821 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.86 23.52 66.61 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.618 -0.993 . . . . 0.6 110.618 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.45 128.43 33.47 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.357 1.078 . . . . 2.67 109.966 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -81.22 125.92 30.89 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.666 -0.414 . . . . 1.42 110.306 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.574 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -126.58 132.55 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.72 -0.474 . . . . 0.36 109.72 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -97.06 132.95 42.34 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.021 -0.425 . . . . 1.61 110.307 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -115.58 131.71 56.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.053 -0.404 . . . . 0.46 110.185 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -104.48 140.96 37.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.108 -0.37 . . . . 1.47 110.189 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.36 115.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.062 -0.718 . . . . 0.15 109.062 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR . 60.6 t -79.2 -43.77 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 -173.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -162.84 135.95 5.78 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.742 -0.383 . . . . 1.78 110.303 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.627 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.0 131.73 52.94 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.917 -0.401 . . . . 0.12 109.917 172.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.14 115.47 18.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.558 -0.734 . . . . 0.28 110.091 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.623 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.5 Cg_endo -74.1 163.42 90.13 Favored 'Cis proline' 0 N--CA 1.502 1.989 0 C-N-CA 124.741 -0.941 . . . . 0.18 110.257 -16.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.627 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 62.4 m -102.37 140.18 20.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 CA-C-O 118.84 -0.6 . . . . 0.24 109.835 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.82 162.66 90.82 Favored 'Cis proline' 0 N--CA 1.501 1.922 0 C-N-CA 124.376 -1.093 . . . . 0.38 110.674 -16.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.66 155.7 44.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.054 -0.404 . . . . 0.15 110.435 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -92.47 142.8 27.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.862 -0.421 . . . . 2.69 109.862 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.7 t -85.38 126.05 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.169 -0.678 . . . . 0.24 109.169 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.35 168.34 17.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.043 -0.354 . . . . 1.65 110.043 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.55 -26.49 63.61 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.975 -0.453 . . . . 2.04 111.497 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -81.59 -20.37 39.97 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.939 -0.476 . . . . 3.49 111.303 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.7 m -77.19 133.47 38.92 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.704 -0.622 . . . . 0.24 109.902 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -88.28 143.87 26.76 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.903 -0.319 . . . . 1.41 110.179 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -126.1 135.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.292 -0.632 . . . . 0.42 109.292 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.9 m -127.03 139.97 52.64 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.783 0.325 . . . . 0.29 110.388 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.47 126.64 45.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.183 -0.323 . . . . 0.43 110.231 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.77 137.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.426 -0.583 . . . . 0.46 109.426 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.47 164.99 31.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.139 -0.351 . . . . 1.34 110.242 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -99.71 154.94 37.0 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.328 -0.368 . . . . 4.7 110.189 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 O-C-N 123.476 1.251 . . . . 4.32 110.219 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 120.73 0.3 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.02 -140.09 3.17 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.95 130.77 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.1 mt -119.31 124.49 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -88.05 117.76 27.15 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.349 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 p -76.89 148.34 36.5 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.704 -0.398 . . . . 0.0 109.988 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -153.2 151.66 30.34 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.962 0.411 . . . . 0.0 110.868 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 tp -127.24 129.38 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -104.11 132.27 50.53 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.066 -0.396 . . . . 0.0 110.37 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.1 mt -127.16 153.98 45.36 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.729 0.3 . . . . 0.0 110.371 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -132.07 128.9 21.58 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.049 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.78 141.21 30.22 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 O-C-N 123.224 1.118 . . . . 0.0 110.257 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 58' ' ' LYS . 33.4 mt -81.22 -48.54 1.05 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.751 -1.595 . . . . 0.0 113.444 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 161.23 45.83 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 121.72 1.65 . . . . 0.0 110.265 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.69 97.81 9.31 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.115 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.43 141.76 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 122.132 -0.355 . . . . 0.0 110.178 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -112.3 111.58 22.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.072 -0.393 . . . . 0.0 110.099 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.9 mt -93.79 127.98 43.5 Favored Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.16 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.68 166.25 5.26 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.836 1.024 . . . . 0.0 111.784 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.17 -9.3 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.232 1.288 . . . . 0.0 112.873 -171.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.99 -30.47 58.58 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.128 0.876 . . . . 0.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -60.3 -44.59 95.26 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.621 -0.675 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.43 -32.91 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 O-C-N 121.792 -0.568 . . . . 0.0 110.651 -171.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.08 -42.15 73.15 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.024 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.86 -39.95 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.32 -42.95 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 O-C-N 121.806 -0.559 . . . . 0.0 109.945 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.56 -41.11 84.86 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.98 -42.36 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.891 -0.506 . . . . 0.0 109.939 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.29 -42.31 93.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.928 -0.482 . . . . 0.0 111.014 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD12 HG22 ' A' ' 33' ' ' ILE . 31.0 mt -90.03 -29.62 18.29 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.922 -0.487 . . . . 0.0 111.752 -167.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.98 147.06 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.632 -0.667 . . . . 0.0 112.411 -173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -26.57 20.59 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.47 155.1 19.52 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.106 0.953 . . . . 0.0 110.147 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.99 147.38 25.06 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.892 0.377 . . . . 0.0 110.251 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.7 144.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 122.117 -0.364 . . . . 0.0 110.416 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -136.02 149.09 48.68 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.1 m -55.61 137.91 48.12 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.749 -0.594 . . . . 0.0 111.515 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.63 57.94 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.25 151.51 43.45 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 118.734 1.267 . . . . 0.0 110.713 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.82 130.18 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.58 151.04 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 122.07 -0.394 . . . . 0.0 110.32 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.04 140.24 15.39 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.5 mt -123.11 135.34 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.4 t -90.06 119.58 30.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.048 -0.407 . . . . 0.0 110.179 171.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 HG11 ' A' ' 57' ' ' VAL . 78.3 mt -126.68 123.78 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.26 32.68 8.51 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.784 -0.572 . . . . 0.0 111.857 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.25 24.04 64.46 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.29 128.86 42.4 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 118.343 1.072 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.17 125.63 30.5 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.323 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.611 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.67 131.88 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' HD12 ' A' ' 20' ' ' LEU . 98.5 mttt -96.4 132.78 41.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.137 -0.352 . . . . 0.0 110.348 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 50' ' ' ILE . 51.0 m-85 -117.5 131.82 56.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.054 -0.404 . . . . 0.0 110.15 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -104.08 140.93 37.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.163 -0.336 . . . . 0.0 110.109 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -84.36 115.9 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -80.5 -42.53 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -164.88 132.8 3.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.098 -0.376 . . . . 0.0 110.54 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.99 133.72 47.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.145 -0.347 . . . . 0.0 110.085 172.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.8 m-85 -129.06 115.69 18.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.114 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.656 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.5 Cg_endo -74.57 163.26 90.84 Favored 'Cis proline' 0 N--CA 1.501 1.958 0 C-N-CA 124.614 -0.994 . . . . 0.0 110.21 -16.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.1 m -102.41 140.13 20.85 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.82 176.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.75 161.29 94.51 Favored 'Cis proline' 0 N--CA 1.502 1.976 0 C-N-CA 124.416 -1.077 . . . . 0.0 110.693 -15.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.82 155.71 44.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.048 -0.408 . . . . 0.0 110.458 169.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -92.32 143.78 26.05 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 63.3 t -82.86 131.49 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.1 163.87 26.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.15 -0.344 . . . . 0.0 110.133 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.96 -29.17 68.25 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.013 -0.43 . . . . 0.0 111.13 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -83.06 -20.47 34.91 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.05 -0.406 . . . . 0.0 111.297 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -68.55 135.83 52.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.704 -0.623 . . . . 0.0 110.041 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -88.07 139.07 30.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.142 -0.349 . . . . 0.0 110.181 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.1 132.33 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -126.49 140.98 52.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.138 -0.351 . . . . 0.0 110.477 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.03 128.04 45.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.07 -0.394 . . . . 0.0 110.154 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.0 t -94.23 136.19 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.37 162.64 38.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.159 -0.338 . . . . 0.0 110.224 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -130.79 92.18 34.99 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 122.08 -0.388 . . . . 0.0 110.278 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.148 1.078 . . . . 0.0 110.693 179.801 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -140.01 30.57 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 131.47 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.033 -0.686 . . . . 0.0 109.258 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.8 mm -116.92 137.81 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -86.66 111.5 20.72 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.063 0.458 . . . . 0.0 110.378 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 p -101.57 152.05 21.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.917 -0.489 . . . . 0.0 110.243 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -150.6 148.38 28.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.866 0.365 . . . . 0.0 110.643 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 42' ' ' VAL . 20.7 tp -128.21 126.17 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 171.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -105.94 132.57 51.88 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.065 -0.397 . . . . 0.0 110.562 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -126.21 150.17 48.53 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -121.45 128.9 25.45 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.843 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.48 137.79 23.49 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.274 1.144 . . . . 0.0 110.185 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.8 mt -75.7 -48.82 3.76 Favored Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 116.743 -1.599 . . . . 0.0 113.299 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.03 154.4 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.676 1.634 . . . . 0.0 110.109 167.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -83.78 92.33 7.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.036 -0.415 . . . . 0.0 110.092 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.15 142.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.025 -0.422 . . . . 0.0 110.105 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -104.74 121.18 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.145 -0.347 . . . . 0.0 110.185 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 29' ' ' PHE . 84.8 mt -93.85 128.0 43.28 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.193 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.62 166.34 6.56 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 O-C-N 123.047 1.025 . . . . 0.0 111.632 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.9 Cg_exo -65.28 -9.28 21.46 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.53 1.279 . . . . 0.0 112.94 -170.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -75.58 -31.07 59.83 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.161 0.891 . . . . 0.0 110.658 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -60.38 -46.39 90.15 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.688 -0.632 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.87 -32.95 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.772 -0.58 . . . . 0.0 110.721 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.73 -41.87 74.72 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.037 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.29 -40.42 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.12 -43.83 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.82 -0.55 . . . . 0.0 110.079 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -60.01 -42.24 93.86 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.825 -0.547 . . . . 0.0 111.062 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.93 -41.46 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.947 -0.47 . . . . 0.0 109.971 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.04 -43.98 85.95 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.985 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.569 HD12 HG22 ' A' ' 33' ' ' ILE . 86.6 mt -89.57 -27.92 19.92 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.932 -0.48 . . . . 0.0 111.924 -165.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.68 145.87 6.35 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 121.614 -0.679 . . . . 0.0 112.312 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 -26.95 18.55 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -89.5 155.13 19.49 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 118.053 0.926 . . . . 0.0 110.023 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -98.67 147.44 24.84 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.926 0.393 . . . . 0.0 110.339 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -129.92 139.87 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.179 -0.326 . . . . 0.0 110.302 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -136.02 151.12 49.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 m -54.78 136.65 46.12 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.796 -0.565 . . . . 0.0 111.669 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.56 58.03 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -63.79 152.61 38.98 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 118.78 1.29 . . . . 0.0 110.726 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.89 129.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.499 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.96 146.69 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.141 -0.349 . . . . 0.0 110.345 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.88 138.85 14.97 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 59' ' ' PHE . 78.1 mt -128.21 132.01 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.7 p -88.72 122.9 32.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.21 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 33' ' ' ILE . 77.5 mt -128.78 130.92 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt 51.86 32.64 10.1 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.779 -0.576 . . . . 0.0 111.723 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.55 24.29 63.16 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -137.93 125.88 22.67 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.241 1.02 . . . . 0.0 110.0 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -81.18 130.83 35.2 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.4 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.6 132.19 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.435 . . . . 0.0 109.904 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' CB ' HD12 ' A' ' 20' ' ' LEU . 74.6 mttt -94.34 131.56 39.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.09 -0.381 . . . . 0.0 110.118 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 50' ' ' ILE . 29.9 m-85 -116.6 131.72 56.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.061 -0.399 . . . . 0.0 110.113 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -101.25 138.79 37.81 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 17' ' ' LEU . 49.8 t -81.59 112.23 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.35 -42.99 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -164.08 131.31 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.97 134.66 46.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.47 116.31 18.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.125 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.648 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.5 Cg_endo -72.14 163.44 87.59 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.194 -15.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.61 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 15.8 m -102.25 143.61 26.94 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.074 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.12 163.67 84.94 Favored 'Cis proline' 0 N--CA 1.501 1.941 0 C-N-CA 124.209 -1.163 . . . . 0.0 110.539 -24.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.51 155.93 45.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.001 -0.437 . . . . 0.0 110.442 173.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -90.14 141.03 29.08 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.16 127.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.29 167.68 18.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.42 -28.19 66.71 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.91 -0.494 . . . . 0.0 111.128 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -80.28 -20.45 44.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.006 -0.434 . . . . 0.0 111.491 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.6 m -78.8 130.52 35.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.728 -0.608 . . . . 0.0 110.059 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -89.18 146.77 24.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.12 -0.362 . . . . 0.0 110.141 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.7 mt -126.19 138.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -128.23 141.92 51.32 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.803 0.335 . . . . 0.0 110.392 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.08 130.08 45.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.092 -0.38 . . . . 0.0 110.321 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.5 t -94.91 143.61 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.0 p -148.02 -49.62 0.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.205 -0.309 . . . . 0.0 110.293 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -105.37 108.31 61.12 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.564 0 O-C-N 123.13 1.069 . . . . 0.0 110.736 178.804 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.68 -142.92 1.12 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.32 142.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -95.3 116.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptp -87.31 118.07 26.49 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.563 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 p -105.37 145.64 30.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.955 -0.466 . . . . 0.0 110.158 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.86 148.35 27.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.088 -0.382 . . . . 0.0 110.558 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 tp -126.95 132.01 50.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.093 -0.379 . . . . 0.0 110.349 176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -102.34 119.94 39.65 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.021 -0.424 . . . . 0.0 110.054 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.7 mt -116.25 153.9 31.08 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.8 0.333 . . . . 0.0 110.365 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -135.03 131.93 20.07 Favored Pre-proline 0 N--CA 1.496 1.873 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.033 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.89 142.03 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.202 1.106 . . . . 0.0 110.246 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 58' ' ' LYS . 74.1 mt -79.36 -48.71 1.48 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.293 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.45 157.27 62.52 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 121.726 1.652 . . . . 0.0 110.135 167.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -83.61 94.42 8.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.221 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.04 142.17 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.021 -0.424 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -112.99 116.72 30.39 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 82.2 mt -93.15 141.78 24.49 Favored Pre-proline 0 N--CA 1.499 1.978 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.259 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.76 165.01 8.77 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 O-C-N 123.217 1.114 . . . . 0.0 111.618 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.78 -9.48 24.78 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.53 1.279 . . . . 0.0 112.77 -174.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -77.4 -28.19 52.62 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.162 0.892 . . . . 0.0 110.814 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.5 m-85 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.614 -0.679 . . . . 0.0 111.251 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.4 p -59.4 -33.01 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.724 -0.61 . . . . 0.0 110.772 -171.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -70.26 -41.89 72.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.039 -0.413 . . . . 0.0 109.908 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.48 -39.57 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.53 -42.56 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 121.843 -0.536 . . . . 0.0 109.966 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.58 -41.65 86.19 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.794 -0.566 . . . . 0.0 111.237 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.89 -43.11 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.963 -0.46 . . . . 0.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -64.25 -42.56 96.46 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.899 -0.501 . . . . 0.0 111.096 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 33' ' ' ILE . 84.3 mt -90.03 -31.04 17.36 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.051 -0.406 . . . . 0.0 111.67 -167.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -51.2 146.59 6.46 Favored 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.69 -0.631 . . . . 0.0 112.357 -172.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.12 18.37 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.2 155.09 19.26 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.037 0.918 . . . . 0.0 110.246 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -99.15 147.55 24.98 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 120.852 0.358 . . . . 0.0 110.261 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.74 145.49 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.105 -0.372 . . . . 0.0 110.494 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -135.38 149.89 49.78 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.2 m -55.22 138.73 44.3 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.698 -0.626 . . . . 0.0 111.589 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.68 57.93 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.29 151.75 42.93 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 118.743 1.272 . . . . 0.0 110.736 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.02 132.64 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.47 150.63 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 122.094 -0.379 . . . . 0.0 110.326 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.98 140.19 15.35 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.572 HD12 ' CD2' ' A' ' 59' ' ' PHE . 81.3 mt -124.53 136.27 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.0 t -89.9 119.5 30.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.013 -0.43 . . . . 0.0 110.218 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.645 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.07 128.95 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 mt 51.41 32.59 8.81 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.748 -0.595 . . . . 0.0 111.803 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.12 23.71 68.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -135.86 133.79 38.13 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.271 1.035 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.89 128.51 33.75 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.42 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.645 HG11 HD12 ' A' ' 52' ' ' ILE . 7.5 p -126.96 131.85 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mmtt -96.47 131.89 42.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.114 -0.366 . . . . 0.0 110.292 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.572 ' CD2' HD12 ' A' ' 50' ' ' ILE . 52.2 m-85 -115.92 131.81 56.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.085 -0.384 . . . . 0.0 110.147 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -105.21 142.87 34.22 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.158 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.2 t -86.47 115.72 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 44' ' ' THR . 59.1 t -79.33 -42.68 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -165.29 133.31 3.13 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.072 -0.392 . . . . 0.0 110.574 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.67 134.94 45.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.12 -0.362 . . . . 0.0 110.025 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.3 m-85 -129.23 118.76 19.36 Favored Pre-proline 0 N--CA 1.498 1.957 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.132 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.9 Cg_endo -74.83 163.74 89.91 Favored 'Cis proline' 0 N--CA 1.502 2.016 0 C-N-CA 124.686 -0.964 . . . . 0.0 110.218 -17.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -101.96 141.52 22.72 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.902 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.03 162.31 91.95 Favored 'Cis proline' 0 N--CA 1.502 2.017 0 C-N-CA 124.286 -1.131 . . . . 0.0 110.61 -17.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.11 155.85 44.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.049 -0.407 . . . . 0.0 110.501 170.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -92.05 142.43 27.52 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -83.11 132.33 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -131.21 163.62 27.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.18 -29.36 68.64 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.962 -0.461 . . . . 0.0 110.973 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -82.04 -20.47 38.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.105 -0.372 . . . . 0.0 111.271 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -68.14 135.75 52.61 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -88.38 138.26 31.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.254 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.12 133.12 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -124.0 142.37 51.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.199 -0.313 . . . . 0.0 110.386 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -99.11 126.31 44.83 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.7 t -93.59 135.0 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -147.46 167.82 23.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.187 -0.32 . . . . 0.0 110.206 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -105.2 155.18 38.19 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.295 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 O-C-N 123.569 1.3 . . . . 0.0 110.261 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -158.17 1.49 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.17 133.78 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.84 129.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.8 ptp -86.07 114.18 22.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.108 0.48 . . . . 0.0 110.598 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 75' ' ' THR . 79.7 p -99.41 154.17 18.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.008 -0.432 . . . . 0.0 109.975 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -150.06 147.77 28.21 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.008 0.433 . . . . 0.0 110.938 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.1 tt -125.01 120.92 32.93 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -103.76 121.79 43.74 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.922 -0.486 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 61' ' ' VAL . 28.1 mt -114.26 154.24 28.28 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -124.5 130.78 24.18 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.77 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.47 137.0 20.18 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.259 1.136 . . . . 0.0 110.287 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.4 mt -82.47 -48.91 0.85 Allowed Pre-proline 0 N--CA 1.502 2.152 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.83 162.77 40.83 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.657 1.627 . . . . 0.0 110.091 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -83.86 97.38 9.17 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.013 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.23 141.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 122.097 -0.377 . . . . 0.0 110.231 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -118.31 109.9 16.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.061 -0.399 . . . . 0.0 109.982 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 29' ' ' PHE . 77.6 mt -93.12 136.77 24.15 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.29 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.4 165.89 8.56 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 O-C-N 123.125 1.066 . . . . 0.0 111.624 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.503 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.38 24.38 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.234 1.289 . . . . 0.0 112.807 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.9 -29.18 55.63 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 119.125 0.875 . . . . 0.0 110.746 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.21 -44.9 94.78 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.587 -0.696 . . . . 0.0 111.093 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.96 -33.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.844 -0.535 . . . . 0.0 110.726 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.04 -42.22 73.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.59 -40.19 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.593 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.5 -42.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.804 -0.56 . . . . 0.0 109.892 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -40.51 85.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.836 -0.54 . . . . 0.0 111.175 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.95 -42.16 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.965 -0.46 . . . . 0.0 109.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -64.94 -42.4 94.68 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.013 -0.429 . . . . 0.0 111.054 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 33' ' ' ILE . 79.8 mt -89.34 -30.8 18.15 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.888 -0.507 . . . . 0.0 111.601 -167.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -51.13 147.84 5.03 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 121.753 -0.592 . . . . 0.0 112.342 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.69 -27.16 18.93 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -89.91 155.11 19.35 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.035 0.917 . . . . 0.0 110.256 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -98.84 148.94 23.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.849 0.357 . . . . 0.0 110.295 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.59 144.89 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.096 -0.377 . . . . 0.0 110.465 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -134.5 147.64 50.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.0 m -55.15 139.34 42.16 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.743 -0.598 . . . . 0.0 111.54 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.74 56.88 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.22 151.35 43.79 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 118.721 1.26 . . . . 0.0 110.72 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.79 130.92 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.514 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -138.18 145.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.78 138.01 14.48 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 59' ' ' PHE . 79.0 mt -126.52 130.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -89.41 122.81 32.97 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.092 -0.38 . . . . 0.0 110.277 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.55 130.86 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.9 mt 51.8 32.69 9.99 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.763 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.23 23.86 64.89 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -135.8 125.81 26.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.332 1.066 . . . . 0.0 110.035 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.95 131.85 35.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 122.054 -0.404 . . . . 0.0 110.406 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.97 130.9 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.005 -0.434 . . . . 0.0 109.942 173.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -94.64 131.32 40.56 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.105 -0.372 . . . . 0.0 110.209 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.9 m-85 -118.09 131.57 56.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.065 -0.397 . . . . 0.0 110.076 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -103.84 137.6 41.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -79.24 111.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.42 -43.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -163.89 132.63 3.75 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.525 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.6 m-85 -129.19 118.54 19.33 Favored Pre-proline 0 N--CA 1.498 1.965 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.978 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.69 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.7 Cg_endo -73.46 163.29 90.02 Favored 'Cis proline' 0 N--CA 1.501 1.957 0 C-N-CA 124.773 -0.928 . . . . 0.0 110.241 -17.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -102.51 141.24 22.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.798 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.61 162.19 91.41 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 C-N-CA 124.328 -1.113 . . . . 0.0 110.635 -17.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.4 155.87 44.52 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.411 . . . . 0.0 110.49 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -91.44 141.96 28.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.77 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -131.28 165.51 23.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -27.41 66.12 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.06 -0.4 . . . . 0.0 111.185 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -81.38 -20.46 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.924 -0.485 . . . . 0.0 111.245 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 13' ' ' SER . 23.0 m -77.23 132.52 38.75 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.694 -0.629 . . . . 0.0 110.05 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -88.94 143.73 26.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.113 -0.367 . . . . 0.0 110.17 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.9 mt -126.03 137.71 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -129.38 144.0 51.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.411 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.87 122.95 42.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.073 -0.392 . . . . 0.0 110.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.01 138.48 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.1 p -147.6 169.03 20.49 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.23 173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -112.37 97.53 40.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 122.057 -0.402 . . . . 0.0 110.188 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.474 0 O-C-N 123.239 1.126 . . . . 0.0 110.67 179.195 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 70.09 2.51 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.2 138.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -106.28 124.46 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -87.62 116.58 25.84 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 p -108.48 148.9 29.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.034 -0.416 . . . . 0.0 110.31 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -151.23 149.15 29.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 69' ' ' LEU . 33.1 mt -129.35 130.48 46.13 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.756 0.312 . . . . 0.0 110.221 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -104.22 129.53 52.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.082 -0.387 . . . . 0.0 110.272 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.8 mt -123.46 152.99 41.1 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.74 0.305 . . . . 0.0 110.344 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -131.92 128.76 21.65 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.913 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.02 141.34 26.45 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 123.22 1.116 . . . . 0.0 110.173 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 58' ' ' LYS . 80.9 mt -78.17 -48.79 1.97 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.277 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.1 158.77 56.53 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.657 1.628 . . . . 0.0 110.124 167.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -84.15 96.65 9.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.051 -0.405 . . . . 0.0 110.184 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.148 -0.345 . . . . 0.0 110.182 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.0 117.12 32.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.105 -0.372 . . . . 0.0 110.122 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' CE2' ' A' ' 29' ' ' PHE . 80.6 mt -93.61 129.72 37.5 Favored Pre-proline 0 N--CA 1.499 1.987 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.215 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.44 166.22 6.47 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.81 1.007 . . . . 0.0 111.735 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.2 Cg_exo -66.12 -9.24 22.76 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 123.52 1.274 . . . . 0.0 112.904 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.97 -30.21 58.53 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.092 0.86 . . . . 0.0 110.619 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.13 -46.55 89.26 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.655 -0.653 . . . . 0.0 111.111 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.3 -32.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.764 -0.585 . . . . 0.0 110.733 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.01 -42.08 73.48 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.004 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.99 -39.95 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.13 -43.96 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.899 -0.501 . . . . 0.0 109.946 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.28 -42.41 91.17 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.842 -0.536 . . . . 0.0 111.063 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.38 -41.36 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 121.877 -0.514 . . . . 0.0 109.996 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -41.5 87.84 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.981 -0.449 . . . . 0.0 111.011 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 33' ' ' ILE . 60.3 mt -88.74 -23.97 22.79 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.901 -0.499 . . . . 0.0 112.124 -165.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.87 144.23 6.74 Favored 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.481 -0.762 . . . . 0.0 112.423 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.82 23.3 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -89.72 153.55 20.62 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 118.155 0.978 . . . . 0.0 110.175 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.88 151.27 21.5 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.819 0.342 . . . . 0.0 110.299 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 15' ' ' LEU . 27.2 m -134.96 143.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 122.154 -0.341 . . . . 0.0 110.504 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -135.25 148.57 49.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.8 m -55.29 137.97 46.34 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.757 -0.589 . . . . 0.0 111.535 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.67 -17.75 57.9 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -64.54 152.63 41.39 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 118.65 1.225 . . . . 0.0 110.728 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.33 133.9 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.03 153.03 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.129 -0.357 . . . . 0.0 110.233 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.74 141.21 16.07 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.6 mt -128.51 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.982 -0.716 . . . . 0.0 109.251 175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.1 t -89.38 118.0 28.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.114 -0.366 . . . . 0.0 110.19 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 ' CG2' ' A' ' 50' ' ' ILE . 51.2 mm -124.3 125.76 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.4 mt 51.06 32.52 7.78 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.816 -0.552 . . . . 0.0 111.871 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.36 22.61 70.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -134.02 135.82 43.64 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.363 1.082 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -79.88 125.42 29.7 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.252 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.14 132.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' A' ' 20' ' ' LEU . 74.0 mttt -97.0 134.53 40.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.089 -0.382 . . . . 0.0 110.336 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.9 m-85 -119.42 131.6 55.67 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.038 -0.414 . . . . 0.0 110.3 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -106.98 141.51 38.07 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.22 -0.3 . . . . 0.0 110.198 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.46 116.84 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 t -79.87 -42.7 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -164.66 130.82 2.88 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.473 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.97 134.18 45.59 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.4 m-85 -129.5 118.64 19.06 Favored Pre-proline 0 N--CA 1.497 1.912 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.243 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.672 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.3 Cg_endo -75.29 163.57 90.25 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.737 -0.943 . . . . 0.0 110.175 -17.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -102.21 141.92 23.52 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 118.786 -0.626 . . . . 0.0 109.85 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.3 161.08 94.75 Favored 'Cis proline' 0 N--CA 1.501 1.949 0 C-N-CA 124.388 -1.088 . . . . 0.0 110.668 -17.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.99 155.61 44.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.989 -0.445 . . . . 0.0 110.503 170.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.41 146.5 23.7 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.11 130.17 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.15 164.25 25.9 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.91 -28.94 68.02 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.935 -0.478 . . . . 0.0 111.081 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -81.93 -20.34 38.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.045 -0.409 . . . . 0.0 111.468 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.5 m -66.95 132.95 49.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.605 -0.685 . . . . 0.0 110.254 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -87.9 134.69 33.66 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.01 132.35 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 139.21 53.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.112 -0.368 . . . . 0.0 110.384 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.62 129.68 46.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.158 -0.339 . . . . 0.0 110.23 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.8 t -93.76 134.82 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -147.71 33.22 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.788 0.328 . . . . 0.0 110.333 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -116.74 96.71 49.14 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.184 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.49 1.323 0 O-C-N 123.346 1.182 . . . . 0.0 110.297 178.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.85 175.37 50.29 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.8 133.07 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -121.84 144.62 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.5 117.3 8.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.094 -0.379 . . . . 0.0 110.597 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' HG23 ' A' ' 75' ' ' THR . 26.8 p -131.06 154.24 48.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.105 -0.372 . . . . 0.0 110.092 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -152.77 150.47 29.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.971 -0.456 . . . . 0.0 110.599 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -131.53 130.97 43.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.068 -0.395 . . . . 0.0 110.112 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -107.81 134.22 51.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.984 -0.448 . . . . 0.0 110.554 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 61' ' ' VAL . 90.1 mt -125.33 154.35 41.94 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -129.88 140.26 38.11 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.969 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.16 139.44 21.38 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 O-C-N 123.38 1.2 . . . . 0.0 110.351 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 58' ' ' LYS . 75.6 mt -82.29 -48.7 0.88 Allowed Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.344 175.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.1 167.0 24.85 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 121.704 1.644 . . . . 0.0 110.072 167.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -83.35 86.58 7.04 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.113 0.482 . . . . 0.0 109.96 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.73 141.55 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.923 -0.486 . . . . 0.0 110.179 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.74 119.28 34.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 29' ' ' PHE . 58.1 mt -93.22 138.95 22.92 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.323 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.2 163.74 11.63 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 O-C-N 123.077 1.041 . . . . 0.0 111.543 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.64 -9.41 24.28 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 O-C-N 123.515 1.271 . . . . 0.0 112.831 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.35 -28.99 53.17 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 119.124 0.875 . . . . 0.0 110.696 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.9 m-85 -59.68 -44.33 93.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.615 -0.678 . . . . 0.0 111.169 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -59.04 -32.97 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.79 -0.569 . . . . 0.0 110.696 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.18 -42.29 72.63 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.971 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.6 t -68.66 -39.49 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.623 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.38 -42.62 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.868 -0.52 . . . . 0.0 109.896 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -58.74 -41.21 85.94 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.888 -0.508 . . . . 0.0 111.224 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' VAL . 72.6 mt -65.61 -41.95 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.899 -0.501 . . . . 0.0 109.982 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -66.13 -44.13 85.09 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.891 -0.505 . . . . 0.0 110.937 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 33' ' ' ILE . 80.3 mt -91.96 -23.64 19.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.908 -0.495 . . . . 0.0 112.177 -166.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.8 149.26 3.5 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.533 -0.729 . . . . 0.0 112.352 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.35 -26.4 21.61 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -88.97 155.06 19.73 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.117 0.958 . . . . 0.0 110.153 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.43 150.45 22.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.135 -0.353 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 15' ' ' LEU . 27.5 m -130.96 144.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 120.849 0.357 . . . . 0.0 110.453 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -132.8 148.47 52.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.5 m -55.44 138.01 47.02 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.765 -0.585 . . . . 0.0 111.554 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.68 57.35 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.33 152.1 42.12 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 118.72 1.26 . . . . 0.0 110.869 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.7 t -129.31 129.51 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.14 148.51 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 122.047 -0.408 . . . . 0.0 110.392 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.84 138.42 14.93 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 87.7 mt -129.31 134.05 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.125 -0.633 . . . . 0.0 109.303 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.8 t -89.03 124.41 34.26 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.106 -0.372 . . . . 0.0 110.205 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.38 129.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt 51.33 32.72 8.75 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.678 -0.639 . . . . 0.0 111.898 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.08 24.37 64.14 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -135.66 125.93 26.45 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 118.298 1.049 . . . . 0.0 109.946 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -80.67 129.96 34.82 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.337 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -125.92 132.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.9 mttp -93.02 128.94 39.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 22.9 m-85 -113.88 131.44 56.28 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.349 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 47' ' ' VAL . 43.5 tptt -102.17 134.04 46.07 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -78.46 110.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.3 t -79.25 -45.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -162.37 135.14 5.82 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.403 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.18 131.81 52.98 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 13.7 m-85 -129.65 117.45 18.54 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.104 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.617 ' O ' HD23 ' A' ' 69' ' ' LEU . 64.8 Cg_endo -73.85 163.95 88.66 Favored 'Cis proline' 0 N--CA 1.502 2.008 0 C-N-CA 124.83 -0.904 . . . . 0.0 110.245 -17.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -101.97 142.29 24.29 Favored Pre-proline 0 N--CA 1.497 1.91 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.86 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.27 162.34 88.36 Favored 'Cis proline' 0 N--CA 1.502 2.001 0 C-N-CA 124.18 -1.175 . . . . 0.0 110.581 -20.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.63 155.73 45.71 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.532 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -93.54 143.99 25.79 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.83 125.51 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.29 166.87 20.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.7 -27.12 64.56 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.897 -0.502 . . . . 0.0 111.414 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.29 -20.31 44.69 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.003 -0.435 . . . . 0.0 111.557 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 13' ' ' SER . 30.4 m -76.94 135.99 38.77 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.11 137.44 32.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.185 -0.322 . . . . 0.0 110.179 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.8 mt -123.54 133.1 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.97 141.36 51.82 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.801 0.334 . . . . 0.0 110.528 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.95 126.95 46.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.106 -0.371 . . . . 0.0 110.184 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.51 133.86 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 p -147.49 158.65 44.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.117 -0.364 . . . . 0.0 110.196 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -140.43 95.66 8.07 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 122.17 -0.331 . . . . 0.0 110.213 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.357 0 O-C-N 123.32 1.168 . . . . 0.0 110.295 178.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.67 131.81 6.48 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.55 138.21 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -108.23 119.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.7 ptp -87.41 117.76 26.4 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.472 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 p -99.02 144.6 27.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.016 -0.428 . . . . 0.0 110.122 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.39 148.9 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 120.971 0.415 . . . . 0.0 110.807 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 71' ' ' VAL . 3.4 tt -127.34 121.57 31.37 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -104.8 132.79 50.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.959 -0.463 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 61' ' ' VAL . 24.7 mt -128.04 154.89 45.16 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.746 0.308 . . . . 0.0 110.628 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.1 128.71 22.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.893 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.04 140.65 25.59 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.261 1.138 . . . . 0.0 110.31 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.3 mt -79.06 -48.83 1.55 Allowed Pre-proline 0 N--CA 1.502 2.146 0 CA-C-O 116.71 -1.614 . . . . 0.0 113.237 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.15 156.49 64.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 CA-C-N 121.734 1.655 . . . . 0.0 110.106 167.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -83.99 97.62 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.053 -0.404 . . . . 0.0 110.207 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.13 140.32 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 122.084 -0.385 . . . . 0.0 110.159 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.14 114.76 29.09 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 29' ' ' PHE . 45.3 mt -94.19 127.81 43.25 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.171 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.42 166.21 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.062 1.032 . . . . 0.0 111.702 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.93 -9.21 22.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 O-C-N 123.526 1.277 . . . . 0.0 112.927 -170.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -75.61 -30.99 59.74 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.143 0.883 . . . . 0.0 110.561 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.6 m-85 -59.99 -45.96 91.02 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.675 -0.641 . . . . 0.0 111.139 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.76 -33.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 121.815 -0.553 . . . . 0.0 110.788 -171.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.05 -41.94 73.54 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.0 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.93 -40.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.26 -43.85 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.806 -0.559 . . . . 0.0 109.993 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -59.67 -41.85 91.56 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.841 -0.537 . . . . 0.0 111.088 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.66 -41.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 122.006 -0.434 . . . . 0.0 110.023 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.42 -42.57 87.58 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.018 -0.426 . . . . 0.0 111.06 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 33' ' ' ILE . 73.0 mt -88.78 -27.91 20.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.886 -0.509 . . . . 0.0 111.919 -165.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.54 146.23 5.75 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.588 -0.695 . . . . 0.0 112.384 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.79 -25.19 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -88.5 154.41 20.37 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.264 1.032 . . . . 0.0 110.019 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -100.18 147.87 25.24 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.21 141.94 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.152 -0.343 . . . . 0.0 110.49 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -134.3 145.82 49.42 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.7 m -54.62 137.86 42.61 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.745 -0.597 . . . . 0.0 111.576 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.59 57.47 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.31 151.81 42.81 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 118.649 1.225 . . . . 0.0 110.691 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.58 132.08 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.448 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.15 151.49 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.342 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 140.77 15.65 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.3 mt -123.06 137.21 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.8 p -89.72 121.0 31.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.074 -0.391 . . . . 0.0 110.136 171.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 79.5 mt -130.03 126.5 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.3 mt 51.28 32.66 8.55 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.796 -0.565 . . . . 0.0 111.875 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.67 24.16 65.62 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -134.36 131.79 38.7 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.242 1.021 . . . . 0.0 110.081 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.01 128.45 33.71 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.85 132.37 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' HD12 ' A' ' 20' ' ' LEU . 50.2 mttp -96.36 132.46 41.84 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.363 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD2' HD12 ' A' ' 50' ' ' ILE . 47.8 m-85 -117.87 131.96 56.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.142 -0.348 . . . . 0.0 110.234 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -102.23 138.89 38.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.176 -0.327 . . . . 0.0 110.188 175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.3 t -80.98 114.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -80.41 -43.58 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -172.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -164.23 129.7 2.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.107 -0.371 . . . . 0.0 110.532 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.99 134.59 44.97 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.1 m-85 -129.02 115.87 18.92 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.131 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 69' ' ' LEU . 63.2 Cg_endo -73.33 163.67 88.99 Favored 'Cis proline' 0 N--CA 1.502 1.998 0 C-N-CA 124.653 -0.978 . . . . 0.0 110.15 -15.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.6 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 m -102.28 142.81 25.34 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.936 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.2 162.92 88.99 Favored 'Cis proline' 0 N--CA 1.501 1.969 0 C-N-CA 124.245 -1.148 . . . . 0.0 110.717 -21.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.46 156.09 45.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.069 -0.394 . . . . 0.0 110.381 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -90.46 142.43 27.75 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 15' ' ' LEU . 59.5 t -83.21 136.0 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -130.97 172.26 12.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 120.852 0.358 . . . . 0.0 110.19 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.88 -28.76 69.73 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.025 -0.422 . . . . 0.0 110.813 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -83.44 -20.64 33.72 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.999 -0.438 . . . . 0.0 111.511 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.3 m -70.36 132.17 45.24 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.795 -0.566 . . . . 0.0 110.098 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -87.68 139.21 30.76 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.114 -0.366 . . . . 0.0 110.014 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -125.9 138.06 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.4 m -130.93 142.43 50.36 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.792 0.33 . . . . 0.0 110.405 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.03 123.67 42.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.114 -0.366 . . . . 0.0 110.228 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.9 t -95.95 148.88 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -145.21 158.09 43.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.082 -0.386 . . . . 0.0 110.207 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -129.25 97.43 25.75 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.116 -0.365 . . . . 0.0 110.238 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 O-C-N 123.291 1.153 . . . . 0.0 110.306 178.196 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 120.687 0.279 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.7 -168.83 27.97 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.5 145.71 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.4 mt -92.59 123.46 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.3 ptm -86.99 115.13 24.17 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.017 0.437 . . . . 0.0 110.557 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 75' ' ' THR . 97.2 p -112.94 158.24 20.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.948 -0.47 . . . . 0.0 110.151 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -152.05 150.37 29.88 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.033 -0.417 . . . . 0.0 110.631 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 42' ' ' VAL . 20.1 tp -128.11 130.14 47.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.105 -0.372 . . . . 0.0 110.106 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -104.23 131.03 51.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.032 -0.418 . . . . 0.0 110.366 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 61' ' ' VAL . 23.5 mt -127.93 152.75 47.5 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.768 0.318 . . . . 0.0 110.311 -174.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -130.74 128.77 22.53 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.006 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.76 139.99 20.39 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.22 1.116 . . . . 0.0 110.215 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -74.49 -48.92 5.22 Favored Pre-proline 0 N--CA 1.503 2.188 0 CA-C-O 116.737 -1.601 . . . . 0.0 113.294 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.48 149.43 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 CA-C-N 121.73 1.654 . . . . 0.0 110.046 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -79.91 110.65 15.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.076 0.465 . . . . 0.0 110.538 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.57 143.12 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.932 -0.48 . . . . 0.0 110.209 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -110.24 106.38 15.77 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -92.85 137.48 23.95 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.35 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.58 166.15 8.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.133 1.07 . . . . 0.0 111.658 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.67 -9.3 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.216 1.277 . . . . 0.0 112.841 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.8 -28.65 55.68 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 119.154 0.888 . . . . 0.0 110.809 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.7 m-85 -59.92 -44.32 94.37 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.553 -0.717 . . . . 0.0 111.197 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.1 p -59.37 -32.77 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.816 -0.552 . . . . 0.0 110.741 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.13 -42.26 72.84 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -40.44 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 37' ' ' LEU . 47.1 mm -63.57 -42.89 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 O-C-N 121.937 -0.477 . . . . 0.0 109.914 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -59.05 -40.46 85.17 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.794 -0.567 . . . . 0.0 111.111 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.0 -42.22 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 O-C-N 121.963 -0.461 . . . . 0.0 109.841 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -64.57 -40.95 96.49 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.054 -0.404 . . . . 0.0 111.047 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 33' ' ' ILE . 78.8 mt -88.48 -33.76 17.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.935 -0.478 . . . . 0.0 111.458 -168.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -51.51 144.83 9.71 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 121.814 -0.554 . . . . 0.0 112.366 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.05 18.18 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -90.02 155.1 19.32 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.095 0.947 . . . . 0.0 110.098 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -98.97 147.56 24.87 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.864 0.364 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -128.71 139.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 122.187 -0.321 . . . . 0.0 110.367 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -134.44 152.03 51.54 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -55.41 135.19 50.53 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.674 -0.641 . . . . 0.0 111.474 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.37 58.57 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.73 152.04 36.78 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 118.796 1.298 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.11 131.8 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.7 150.75 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 122.099 -0.376 . . . . 0.0 110.252 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.57 138.96 14.83 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 52' ' ' ILE . 80.4 mt -127.16 137.45 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -89.94 117.35 28.68 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.16 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.569 HD12 HG11 ' A' ' 57' ' ' VAL . 74.3 mt -131.52 137.55 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.59 32.74 12.23 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.747 -0.596 . . . . 0.0 111.189 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.99 21.75 75.58 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -140.01 137.78 34.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 118.472 1.136 . . . . 0.0 110.302 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -80.85 127.96 33.13 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.074 -0.391 . . . . 0.0 110.206 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG11 HD12 ' A' ' 52' ' ' ILE . 7.2 p -127.61 132.05 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -96.1 131.4 42.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.159 -0.338 . . . . 0.0 110.302 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 50' ' ' ILE . 45.5 m-85 -114.77 131.79 56.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.062 -0.399 . . . . 0.0 110.253 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.39 140.06 37.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.15 -0.344 . . . . 0.0 110.118 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 17' ' ' LEU . 53.1 t -83.62 112.43 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.0 -44.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -164.43 131.0 3.03 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 122.028 -0.42 . . . . 0.0 110.655 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.42 136.2 45.41 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 m-85 -129.5 118.47 19.01 Favored Pre-proline 0 N--CA 1.498 1.943 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.942 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.651 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.3 Cg_endo -72.89 163.84 88.08 Favored 'Cis proline' 0 N--CA 1.5 1.89 0 C-N-CA 124.777 -0.926 . . . . 0.0 110.195 -16.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.3 m -102.08 144.28 28.28 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.042 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 163.98 83.99 Favored 'Cis proline' 0 N--CA 1.502 1.981 0 C-N-CA 124.152 -1.187 . . . . 0.0 110.542 -24.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.22 156.04 44.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.062 -0.399 . . . . 0.0 110.534 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -90.15 141.09 29.03 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.57 133.74 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.21 163.78 27.0 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -59.88 -29.23 68.18 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 122.022 -0.423 . . . . 0.0 111.042 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -81.92 -20.51 38.57 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.998 -0.439 . . . . 0.0 111.363 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' OG ' ' A' ' 13' ' ' SER . 19.2 m -67.69 136.36 54.2 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.734 -0.604 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -87.73 139.14 30.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.071 -0.393 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.5 mt -126.05 136.16 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 m -126.51 139.96 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.779 0.323 . . . . 0.0 110.387 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.8 mt -98.68 126.49 44.3 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.75 136.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -148.3 -52.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 122.144 -0.347 . . . . 0.0 110.095 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -131.07 92.68 32.66 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 122.095 -0.378 . . . . 0.0 110.094 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 O-C-N 123.354 1.186 . . . . 0.0 110.248 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.3 173.62 31.26 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.52 136.79 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.0 138.76 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 ptp -145.57 119.79 9.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.083 -0.386 . . . . 0.0 110.415 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.544 ' OG ' HG23 ' A' ' 75' ' ' THR . 88.0 p -112.88 158.89 19.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.114 -0.366 . . . . 0.0 110.304 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -149.48 147.48 28.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.072 -0.392 . . . . 0.0 110.381 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 tp -128.96 129.15 45.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.179 -0.326 . . . . 0.0 110.144 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -104.35 130.69 52.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 122.034 -0.416 . . . . 0.0 110.435 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 61' ' ' VAL . 43.7 mt -125.29 154.85 41.09 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 120.732 0.301 . . . . 0.0 110.339 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -133.34 130.85 21.29 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.973 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.83 142.6 32.06 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.254 1.133 . . . . 0.0 110.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 58' ' ' LYS . 63.8 mt -82.74 -48.58 0.82 Allowed Pre-proline 0 N--CA 1.501 2.117 0 CA-C-O 116.758 -1.592 . . . . 0.0 113.41 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.74 158.34 58.21 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.721 1.65 . . . . 0.0 110.171 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.98 95.23 8.47 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.051 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.08 142.07 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 122.092 -0.38 . . . . 0.0 110.169 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -107.76 112.59 25.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.122 -0.361 . . . . 0.0 110.077 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.2 mt -93.05 132.44 30.81 Favored Pre-proline 0 N--CA 1.499 1.976 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.237 -176.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.69 166.33 8.39 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 O-C-N 123.189 1.099 . . . . 0.0 111.575 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.5 Cg_exo -65.73 -9.32 22.39 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.263 1.309 . . . . 0.0 112.97 -171.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -75.64 -30.08 59.36 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 119.18 0.9 . . . . 0.0 110.75 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.57 -45.16 92.66 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.632 -0.667 . . . . 0.0 111.189 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.3 p -59.19 -33.06 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.746 -0.596 . . . . 0.0 110.72 -171.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.14 -42.08 73.03 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.068 -0.395 . . . . 0.0 109.957 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.3 t -68.83 -39.92 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 37' ' ' LEU . 46.7 mm -63.42 -42.55 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 O-C-N 121.934 -0.479 . . . . 0.0 109.941 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -58.7 -41.0 85.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.819 -0.551 . . . . 0.0 111.195 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.0 mt -65.87 -41.21 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 122.002 -0.437 . . . . 0.0 109.921 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -64.48 -41.91 96.19 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.917 -0.489 . . . . 0.0 111.098 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD12 HG22 ' A' ' 33' ' ' ILE . 84.4 mt -88.74 -31.87 18.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.861 -0.524 . . . . 0.0 111.533 -167.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -51.4 144.85 9.33 Favored 'General case' 0 N--CA 1.513 2.695 0 O-C-N 121.761 -0.587 . . . . 0.0 112.359 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.41 -27.38 17.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -90.29 155.08 19.24 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.067 0.934 . . . . 0.0 110.173 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -98.27 147.14 24.94 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.24 143.87 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 122.157 -0.34 . . . . 0.0 110.46 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -135.12 150.25 50.17 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -55.18 136.88 48.11 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.766 -0.584 . . . . 0.0 111.582 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.6 58.03 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.77 152.22 39.95 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-N 118.742 1.271 . . . . 0.0 110.742 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.91 132.17 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.46 153.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.095 -0.378 . . . . 0.0 110.291 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.44 142.19 16.56 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.2 mt -124.55 135.85 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 122.029 -0.689 . . . . 0.0 109.203 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -90.01 120.58 31.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 122.096 -0.377 . . . . 0.0 110.168 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.651 HD12 HG11 ' A' ' 57' ' ' VAL . 77.5 mt -129.3 126.23 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.7 mt 51.46 32.56 8.9 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.815 -0.553 . . . . 0.0 111.797 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.6 24.16 65.81 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -133.43 131.23 39.72 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.309 1.055 . . . . 0.0 110.023 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.12 127.44 32.64 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.314 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.08 133.21 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' HD12 ' A' ' 20' ' ' LEU . 89.2 mttt -96.12 136.3 36.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.163 -0.336 . . . . 0.0 110.463 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 50' ' ' ILE . 41.8 m-85 -123.52 131.79 53.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.987 -0.446 . . . . 0.0 110.239 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -104.27 142.03 35.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.131 -0.356 . . . . 0.0 110.214 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.5 t -85.66 115.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 44' ' ' THR . 61.7 t -79.83 -42.35 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -165.54 133.99 3.17 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 120.861 0.362 . . . . 0.0 110.52 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 134.13 47.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.2 m-85 -129.44 120.28 19.79 Favored Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.091 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.727 ' O ' HD23 ' A' ' 69' ' ' LEU . 70.3 Cg_endo -74.51 163.46 90.32 Favored 'Cis proline' 0 N--CA 1.502 1.996 0 C-N-CA 124.678 -0.967 . . . . 0.0 110.22 -17.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.5 m -102.33 143.85 27.43 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.901 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.11 160.75 93.38 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 124.278 -1.134 . . . . 0.0 110.594 -19.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.2 155.59 44.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.052 -0.405 . . . . 0.0 110.559 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.92 143.47 26.46 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.7 t -82.32 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -131.22 165.37 23.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.181 -0.324 . . . . 0.0 110.165 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.53 -27.87 66.58 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.963 -0.461 . . . . 0.0 111.167 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.39 -20.61 40.14 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.958 -0.464 . . . . 0.0 111.366 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.544 HG23 ' OG ' ' A' ' 13' ' ' SER . 21.9 m -72.32 129.89 39.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.682 -0.636 . . . . 0.0 110.04 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.75 143.22 26.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.1 -0.375 . . . . 0.0 110.319 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.9 mt -125.92 139.52 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.6 m -125.93 141.1 52.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.738 0.304 . . . . 0.0 110.348 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.6 119.92 38.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.135 -0.353 . . . . 0.0 110.233 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.01 141.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -147.04 152.89 39.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 122.102 -0.374 . . . . 0.0 110.222 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -132.35 92.08 29.33 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.49 1.315 0 O-C-N 123.367 1.193 . . . . 0.0 110.306 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.42 -40.23 2.58 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.78 130.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.983 -0.716 . . . . 0.0 109.283 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.17 131.91 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.6 ptm -86.26 115.9 24.1 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.994 0.426 . . . . 0.0 110.341 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -120.16 155.04 33.89 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.945 -0.472 . . . . 0.0 110.219 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -152.15 149.03 28.33 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 HD11 ' A' ' 17' ' ' LEU . 21.3 tp -118.98 129.81 55.35 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.815 0.341 . . . . 0.0 110.135 173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -100.37 116.57 32.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 15' ' ' LEU . 46.9 mt -119.28 152.97 35.79 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 120.758 0.313 . . . . 0.0 110.436 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -134.64 135.85 24.35 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.147 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.97 140.67 25.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.328 1.173 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 58' ' ' LYS . 36.1 mt -76.42 -48.75 3.1 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.769 -1.586 . . . . 0.0 113.302 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.57 155.65 68.25 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.635 1.619 . . . . 0.0 110.078 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.62 89.36 7.1 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.018 0.437 . . . . 0.0 110.141 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.12 143.11 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.966 -0.459 . . . . 0.0 110.205 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -104.88 122.26 45.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 29' ' ' PHE . 86.1 mt -93.82 129.64 37.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.274 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.86 166.42 6.79 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 O-C-N 123.068 1.036 . . . . 0.0 111.661 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.73 -9.35 22.5 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.228 1.285 . . . . 0.0 112.934 -170.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -76.06 -30.73 58.48 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.17 0.896 . . . . 0.0 110.643 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.0 -45.92 91.17 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.564 -0.71 . . . . 0.0 111.087 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -59.03 -32.93 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.841 -0.537 . . . . 0.0 110.733 -171.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -69.97 -42.01 73.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.034 -0.417 . . . . 0.0 109.997 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.82 -40.26 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.918 -0.489 . . . . 0.0 109.976 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.01 -42.01 89.1 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.782 -0.573 . . . . 0.0 111.123 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.8 -43.0 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 121.929 -0.482 . . . . 0.0 109.974 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -65.31 -43.03 92.36 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.958 -0.464 . . . . 0.0 111.029 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 79.1 mt -90.06 -29.54 18.31 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.872 -0.518 . . . . 0.0 111.728 -167.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -51.17 147.16 5.71 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.682 -0.636 . . . . 0.0 112.391 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.43 -26.99 19.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -89.53 155.05 19.53 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.075 0.937 . . . . 0.0 110.151 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.18 147.76 24.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.131 -0.355 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.39 145.07 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 122.177 -0.327 . . . . 0.0 110.381 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -136.0 150.86 49.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 62' ' ' VAL . 17.1 m -55.52 136.84 49.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.773 -0.579 . . . . 0.0 111.466 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.6 -17.78 57.89 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.68 153.05 40.73 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 118.651 1.225 . . . . 0.0 110.882 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' HD2' ' A' ' 60' ' ' LYS . 59.1 t -126.81 130.48 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.41 152.37 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.357 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.89 142.58 16.85 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.609 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.3 mt -125.8 135.47 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 122.082 -0.658 . . . . 0.0 109.238 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.23 121.22 32.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 122.09 -0.381 . . . . 0.0 110.173 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 HG11 ' A' ' 57' ' ' VAL . 76.7 mt -129.28 125.12 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.3 mt 51.27 32.67 8.52 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.818 -0.551 . . . . 0.0 111.81 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 23.7 66.24 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -131.71 130.74 42.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 118.39 1.095 . . . . 0.0 109.999 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.37 127.35 32.67 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.416 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 52' ' ' ILE . 7.6 p -127.17 131.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.545 ' HB3' HD12 ' A' ' 20' ' ' LEU . 44.2 mtmt -95.26 135.17 37.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.132 -0.355 . . . . 0.0 110.236 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 50' ' ' ILE . 31.5 m-85 -120.58 132.02 54.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.052 -0.405 . . . . 0.0 110.501 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 47' ' ' VAL . 46.8 tptt -99.2 136.78 38.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.4 t -83.76 112.05 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' THR . 61.0 t -78.54 -43.85 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -164.5 135.93 4.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.041 -0.412 . . . . 0.0 110.669 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.87 132.39 49.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.1 m-85 -129.1 115.63 18.8 Favored Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.082 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.64 ' O ' HD23 ' A' ' 69' ' ' LEU . 69.2 Cg_endo -74.32 163.39 90.37 Favored 'Cis proline' 0 N--CA 1.501 1.945 0 C-N-CA 124.698 -0.959 . . . . 0.0 110.149 -16.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 54.9 m -102.39 139.8 20.56 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.833 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 161.89 93.32 Favored 'Cis proline' 0 N--CA 1.501 1.948 0 C-N-CA 124.397 -1.085 . . . . 0.0 110.657 -15.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.62 155.75 44.99 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.084 -0.385 . . . . 0.0 110.468 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -92.76 143.63 26.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.4 t -82.72 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.17 176.84 7.93 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.811 0.339 . . . . 0.0 110.1 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.77 -28.99 69.84 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 122.029 -0.42 . . . . 0.0 110.881 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -83.8 -20.81 32.6 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.993 -0.442 . . . . 0.0 111.374 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 m -77.69 131.78 37.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.654 -0.654 . . . . 0.0 110.222 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -88.29 146.96 25.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.06 132.33 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.5 m -123.68 142.52 50.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.182 -0.324 . . . . 0.0 110.258 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -98.25 127.17 44.05 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.174 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.9 t -93.67 138.51 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 p -148.37 -47.44 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.252 173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -101.43 158.87 30.96 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.231 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.412 1.217 . . . . 0.0 110.716 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.47 -141.09 9.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.76 151.57 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 122.087 -0.655 . . . . 0.0 109.247 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -76.19 138.22 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -85.13 112.99 21.18 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.13 0.491 . . . . 0.0 110.349 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 95.6 p -91.88 164.1 13.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.968 -0.457 . . . . 0.0 110.188 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -149.94 148.23 28.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 122.086 -0.384 . . . . 0.0 110.679 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -124.83 127.2 46.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 173.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -101.16 117.36 34.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.101 -0.375 . . . . 0.0 110.014 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 61' ' ' VAL . 85.0 mt -114.35 155.3 26.52 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.756 0.312 . . . . 0.0 110.196 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -135.61 134.06 20.65 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.062 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.66 142.31 25.77 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.269 1.142 . . . . 0.0 110.201 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 58' ' ' LYS . 29.7 mt -79.08 -48.57 1.56 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.362 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.79 156.2 66.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.722 1.651 . . . . 0.0 110.337 167.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -79.58 88.98 5.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.326 0.584 . . . . 0.0 110.506 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.58 141.33 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.838 -0.539 . . . . 0.0 110.152 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -109.44 120.26 41.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.058 -0.401 . . . . 0.0 110.055 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.523 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.6 mt -93.59 128.82 40.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.259 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.69 166.33 6.68 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.841 1.027 . . . . 0.0 111.653 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.72 -9.3 22.31 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 O-C-N 123.573 1.302 . . . . 0.0 112.921 -170.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.99 -30.73 58.66 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 119.201 0.91 . . . . 0.0 110.663 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.523 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.2 m-85 -60.07 -45.68 92.1 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.785 -0.572 . . . . 0.0 111.128 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.9 p -58.81 -32.87 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.815 -0.553 . . . . 0.0 110.734 -171.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.95 -41.93 73.88 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.006 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.9 -40.2 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.4 -43.82 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.897 -0.502 . . . . 0.0 109.961 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -59.86 -41.16 90.88 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.857 -0.527 . . . . 0.0 111.067 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.78 -41.22 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 O-C-N 121.889 -0.507 . . . . 0.0 109.959 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.92 -43.4 88.25 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.987 -0.445 . . . . 0.0 111.099 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 33' ' ' ILE . 78.3 mt -89.41 -27.17 20.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.926 -0.484 . . . . 0.0 111.897 -165.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -50.33 145.31 6.37 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 121.614 -0.679 . . . . 0.0 112.464 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.95 -25.71 24.05 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.75 155.05 19.45 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.094 0.947 . . . . 0.0 110.101 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -99.26 146.92 25.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.863 0.363 . . . . 0.0 110.302 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -130.87 140.33 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 122.125 -0.359 . . . . 0.0 110.339 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -136.15 149.94 48.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.6 m -54.62 138.54 41.07 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.833 -0.542 . . . . 0.0 111.719 -174.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.14 -17.73 58.19 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.1 152.2 41.11 Favored 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 118.63 1.215 . . . . 0.0 110.688 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 132.88 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.5 153.6 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.121 -0.362 . . . . 0.0 110.277 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.06 142.29 16.47 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.8 mt -127.22 136.0 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -89.62 120.08 30.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.125 -0.36 . . . . 0.0 110.096 171.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.684 HD12 HG11 ' A' ' 57' ' ' VAL . 77.8 mt -129.76 127.28 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.8 mt 51.31 32.6 8.56 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.72 -0.613 . . . . 0.0 111.829 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.52 23.72 67.01 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -133.39 132.61 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.294 1.047 . . . . 0.0 110.094 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.25 125.44 30.33 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.313 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -124.17 133.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB3' HD12 ' A' ' 20' ' ' LEU . 92.4 mttt -96.27 134.34 39.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.1 m-85 -120.64 131.81 54.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.098 -0.376 . . . . 0.0 110.152 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -106.77 143.93 34.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.033 -0.417 . . . . 0.0 110.147 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -87.96 116.32 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 44' ' ' THR . 60.5 t -79.77 -42.39 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -164.69 132.83 3.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.065 -0.397 . . . . 0.0 110.593 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.27 134.96 45.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.6 m-85 -129.3 116.95 18.75 Favored Pre-proline 0 N--CA 1.497 1.899 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.161 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.632 ' O ' HD23 ' A' ' 69' ' ' LEU . 62.0 Cg_endo -72.98 163.33 89.55 Favored 'Cis proline' 0 N--CA 1.502 1.982 0 C-N-CA 124.635 -0.985 . . . . 0.0 110.132 -17.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.6 m -102.37 143.76 27.24 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.51 162.42 88.66 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.548 -23.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.39 155.86 45.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.09 -0.381 . . . . 0.0 110.285 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -90.76 142.14 28.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.4 t -83.81 129.18 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.08 178.53 6.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.179 -0.326 . . . . 0.0 110.125 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.72 -29.1 69.89 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 122.036 -0.415 . . . . 0.0 110.889 169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -83.53 -20.88 33.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.013 -0.43 . . . . 0.0 111.444 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 15.4 m -77.42 126.37 30.81 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.715 -0.616 . . . . 0.0 110.183 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.77 144.36 26.03 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.13 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.7 136.3 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.0 m -127.42 149.04 50.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.104 -0.373 . . . . 0.0 110.295 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.12 126.28 42.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -93.67 137.51 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -119.01 96.66 50.34 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 122.114 -0.366 . . . . 0.0 110.211 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.49 1.317 0 O-C-N 123.321 1.169 . . . . 0.0 110.275 177.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.58 -139.94 9.82 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.97 142.44 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.056 -0.673 . . . . 0.0 109.249 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.37 132.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -86.17 114.58 23.12 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.127 0.489 . . . . 0.0 110.558 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.7 p -97.76 162.05 13.46 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.902 -0.499 . . . . 0.0 110.07 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.65 151.48 31.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.051 -0.406 . . . . 0.0 110.858 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 17' ' ' LEU . 18.8 tp -122.5 131.59 53.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.077 -0.389 . . . . 0.0 110.221 172.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -101.19 118.93 37.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.093 -0.38 . . . . 0.0 110.016 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 61' ' ' VAL . 42.6 mt -118.12 153.79 33.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.192 -0.317 . . . . 0.0 110.332 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -134.11 128.6 19.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.985 -0.531 . . . . 0.0 109.973 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.79 137.49 38.52 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.31 1.163 . . . . 0.0 110.161 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.2 mt -75.33 -48.84 4.09 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 113.203 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.83 157.96 59.76 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 CA-C-N 121.665 1.63 . . . . 0.0 110.057 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.45 88.1 6.99 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.34 142.59 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.0 -0.438 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -115.75 127.62 55.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.414 . . . . 0.0 110.261 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 29' ' ' PHE . 37.9 mt -93.46 144.92 29.04 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.261 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.79 162.4 10.93 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 O-C-N 123.186 1.098 . . . . 0.0 111.739 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.5 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.6 Cg_exo -66.8 -9.44 24.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.435 1.229 . . . . 0.0 112.798 -172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.57 -29.84 52.32 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 119.0 0.818 . . . . 0.0 110.654 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -59.75 -43.99 94.01 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.614 -0.679 . . . . 0.0 111.187 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.03 -32.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.849 -0.532 . . . . 0.0 110.664 -171.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -69.94 -42.56 73.09 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.065 -0.397 . . . . 0.0 109.994 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 35' ' ' ILE . 59.5 t -68.72 -39.73 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 37' ' ' LEU . 46.9 mm -63.61 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.892 -0.505 . . . . 0.0 109.835 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -58.25 -40.34 81.53 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.75 -0.593 . . . . 0.0 111.143 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 32' ' ' VAL . 78.1 mt -65.37 -42.62 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.917 -0.49 . . . . 0.0 109.923 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -64.22 -42.4 96.61 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.899 -0.501 . . . . 0.0 111.187 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 33' ' ' ILE . 87.5 mt -89.5 -31.15 17.79 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.887 -0.508 . . . . 0.0 111.543 -168.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.25 146.83 6.25 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.683 -0.636 . . . . 0.0 112.443 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.46 -27.04 18.96 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -89.84 155.08 19.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.032 0.916 . . . . 0.0 110.153 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.0 m -98.63 147.52 24.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.148 -0.345 . . . . 0.0 110.326 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -129.91 143.69 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 122.193 -0.317 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -132.76 148.67 52.33 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.8 m -54.92 137.99 44.31 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.8 57.7 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -63.94 152.75 39.08 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.689 1.245 . . . . 0.0 110.722 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.2 t -134.04 135.69 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.24 153.31 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 122.165 -0.335 . . . . 0.0 110.31 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.89 141.35 16.14 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.599 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.7 mt -127.74 135.32 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 122.087 -0.655 . . . . 0.0 109.274 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -90.11 124.5 34.86 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.175 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.592 HD12 HG11 ' A' ' 57' ' ' VAL . 78.5 mt -129.49 123.43 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.2 mt 51.35 32.6 8.66 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.842 -0.536 . . . . 0.0 111.919 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.07 24.29 64.34 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -131.05 128.67 40.74 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 118.275 1.037 . . . . 0.0 109.963 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.48 128.16 33.26 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG11 HD12 ' A' ' 52' ' ' ILE . 8.1 p -128.51 131.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CB ' HD12 ' A' ' 20' ' ' LEU . 68.0 mttt -94.49 134.31 37.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.189 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' HD12 ' A' ' 50' ' ' ILE . 38.2 m-85 -118.07 131.43 56.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.115 -0.365 . . . . 0.0 110.194 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -106.63 142.38 36.38 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.138 -0.351 . . . . 0.0 110.247 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.511 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.4 t -84.74 113.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.46 -43.27 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -163.1 135.0 5.13 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.554 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -101.82 133.63 46.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 6.8 m-85 -129.11 114.08 18.6 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.237 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' O ' HD23 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -75.38 163.45 90.47 Favored 'Cis proline' 0 N--CA 1.504 2.092 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.238 -14.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 58.8 m -102.18 140.77 21.45 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.824 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.01 161.2 94.85 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.393 -1.086 . . . . 0.0 110.651 -14.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -143.74 155.7 44.27 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.014 -0.429 . . . . 0.0 110.571 170.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -92.1 143.74 26.14 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -82.42 130.42 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.17 163.74 27.04 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -59.79 -28.73 67.68 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 122.024 -0.422 . . . . 0.0 111.186 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -81.73 -20.45 39.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.055 -0.403 . . . . 0.0 111.325 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.2 m -67.41 135.53 53.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.744 -0.598 . . . . 0.0 110.118 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -87.06 138.8 31.18 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.053 -0.404 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.6 mt -126.27 129.95 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -120.76 139.96 52.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.123 -0.36 . . . . 0.0 110.333 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -100.15 122.16 42.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.206 -0.309 . . . . 0.0 110.197 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t -94.23 144.23 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.6 p -146.61 164.04 33.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 122.125 -0.36 . . . . 0.0 110.291 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -122.47 91.39 49.36 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 122.055 -0.403 . . . . 0.0 110.083 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.491 1.326 0 O-C-N 123.427 1.225 . . . . 0.0 110.283 179.452 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.69 70.3 1.11 Allowed Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.41 139.24 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.909 -0.76 . . . . 0.0 109.029 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -111.22 122.46 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -88.0 114.87 25.04 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.387 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.539 ' OG ' HG23 ' A' ' 75' ' ' THR . 80.2 p -105.88 155.61 19.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.992 -0.442 . . . . 0.0 110.266 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -149.11 145.96 27.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.051 -0.405 . . . . 0.0 110.535 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 42' ' ' VAL . 20.0 tp -128.34 124.64 36.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.771 0.32 . . . . 0.0 110.175 174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.11 121.21 42.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.99 -0.444 . . . . 0.0 110.163 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 61' ' ' VAL . 81.1 mt -114.77 153.83 29.64 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -126.51 131.29 23.86 Favored Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.976 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.45 140.34 24.15 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 O-C-N 123.239 1.126 . . . . 0.0 110.303 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 58' ' ' LYS . 24.1 mt -81.93 -48.38 0.95 Allowed Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 116.699 -1.619 . . . . 0.0 113.429 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.43 157.18 62.91 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.769 1.667 . . . . 0.0 110.243 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -83.77 93.13 7.89 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.89 0.376 . . . . 0.0 110.148 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.27 143.58 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.953 -0.467 . . . . 0.0 110.229 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -107.76 120.83 43.36 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.129 -0.357 . . . . 0.0 110.12 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 29' ' ' PHE . 86.9 mt -93.82 127.99 43.39 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.263 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.38 166.28 6.29 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 O-C-N 123.001 1.0 . . . . 0.0 111.676 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.4 Cg_exo -65.97 -9.4 23.09 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.314 1.343 . . . . 0.0 112.876 -172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.92 -29.85 58.54 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.169 0.895 . . . . 0.0 110.692 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.1 m-85 -59.88 -45.7 91.66 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.626 -0.671 . . . . 0.0 111.173 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.6 p -58.69 -33.12 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.723 -0.61 . . . . 0.0 110.773 -171.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -70.0 -41.8 73.87 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.85 -40.09 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -63.24 -44.0 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.872 -0.518 . . . . 0.0 110.028 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.822 -0.548 . . . . 0.0 111.089 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.82 -42.03 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.943 -0.473 . . . . 0.0 109.963 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.42 -42.81 87.18 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 122.009 -0.432 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 33' ' ' ILE . 45.9 mt -89.57 -26.61 20.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.839 -0.538 . . . . 0.0 112.057 -165.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.39 145.54 6.23 Favored 'General case' 0 N--CA 1.515 2.804 0 O-C-N 121.594 -0.691 . . . . 0.0 112.417 -174.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.09 -26.61 20.15 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -89.49 155.09 19.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.122 0.961 . . . . 0.0 110.116 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.3 m -99.84 148.79 24.05 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 120.873 0.368 . . . . 0.0 110.396 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 15' ' ' LEU . 27.7 m -131.23 141.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 122.165 -0.335 . . . . 0.0 110.281 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -136.0 147.68 48.09 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 62' ' ' VAL . 12.7 m -54.83 138.89 41.62 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.767 -0.583 . . . . 0.0 111.626 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.72 57.95 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.11 151.66 42.58 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.706 1.253 . . . . 0.0 110.718 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.77 129.56 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.81 144.94 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.378 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.21 138.07 14.44 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.1 mt -126.88 133.58 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 122.113 -0.639 . . . . 0.0 109.282 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -88.68 121.63 31.25 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.157 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.59 131.2 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.8 mt 51.63 32.59 9.38 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.739 -0.601 . . . . 0.0 111.807 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.72 23.52 66.96 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -137.12 128.43 28.1 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.316 1.058 . . . . 0.0 110.023 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -80.56 131.59 35.55 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.326 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.5 130.98 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.1 mttt -93.89 130.07 40.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.172 -0.33 . . . . 0.0 110.11 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.7 m-85 -115.75 131.56 56.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 122.081 -0.387 . . . . 0.0 110.023 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -104.05 141.22 36.59 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.491 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.2 t -84.01 114.9 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 44' ' ' THR . 59.5 t -79.75 -43.09 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -164.24 130.96 3.12 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.519 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.47 136.3 43.46 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 m-85 -129.66 119.86 19.39 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.094 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.6 Cg_endo -72.34 163.74 87.23 Favored 'Cis proline' 0 N--CA 1.502 1.983 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.245 -17.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.1 m -102.12 143.96 27.64 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.053 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 163.99 82.15 Favored 'Cis proline' 0 N--CA 1.502 1.975 0 C-N-CA 124.165 -1.181 . . . . 0.0 110.464 -25.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.98 155.77 45.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.003 -0.435 . . . . 0.0 110.411 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -90.69 141.34 28.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -81.43 130.52 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -131.14 165.69 22.73 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -59.36 -28.29 66.72 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.972 -0.455 . . . . 0.0 111.198 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -81.85 -20.62 38.57 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.458 . . . . 0.0 111.379 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.539 HG23 ' OG ' ' A' ' 13' ' ' SER . 22.3 m -69.18 130.83 43.78 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.699 -0.626 . . . . 0.0 110.071 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -89.89 139.23 30.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.175 -0.328 . . . . 0.0 110.145 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.1 mt -125.64 136.7 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -129.38 145.31 51.42 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.04 127.31 44.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.072 -0.393 . . . . 0.0 110.144 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.1 139.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.2 p -146.48 160.51 42.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 172.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.07 96.25 29.24 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 122.09 -0.382 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.363 0 O-C-N 123.349 1.184 . . . . 0.0 110.268 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.23 -40.19 2.6 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.47 132.88 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.945 -0.738 . . . . 0.0 109.257 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.4 mt -118.33 138.78 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -85.49 114.95 22.91 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.324 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -118.98 154.67 32.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.982 -0.449 . . . . 0.0 110.275 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -150.05 148.34 28.9 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 120.878 0.37 . . . . 0.0 110.655 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 16' ' ' LYS . 3.5 tt -126.97 122.69 35.24 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' N ' HD23 ' A' ' 15' ' ' LEU . 21.6 mttp -105.99 133.33 50.88 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.055 -0.403 . . . . 0.0 110.55 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 26.6 mt -128.21 154.04 46.26 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.855 0.36 . . . . 0.0 110.657 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -132.53 133.21 23.3 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 109.955 173.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.05 142.29 24.62 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.29 1.152 . . . . 0.0 110.334 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.52 -48.66 0.65 Allowed Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 116.711 -1.614 . . . . 0.0 113.313 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.56 168.6 20.81 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.669 1.632 . . . . 0.0 110.064 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -83.59 95.49 8.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.111 -0.368 . . . . 0.0 110.074 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.74 143.39 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.104 -0.373 . . . . 0.0 110.209 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.56 112.91 13.61 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 29' ' ' PHE . 81.7 mt -92.66 143.33 26.92 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.302 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.78 164.91 8.97 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 O-C-N 123.311 1.164 . . . . 0.0 111.689 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.63 -9.39 24.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.261 1.308 . . . . 0.0 112.807 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.31 -28.95 53.4 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 119.102 0.864 . . . . 0.0 110.714 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.0 m-85 -59.56 -45.65 91.21 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.626 -0.671 . . . . 0.0 111.131 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.58 -32.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.755 -0.591 . . . . 0.0 110.708 -171.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.13 -41.94 73.26 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.003 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 35' ' ' ILE . 62.1 t -68.93 -39.53 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG22 HD12 ' A' ' 37' ' ' LEU . 46.4 mm -63.3 -43.59 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 121.902 -0.499 . . . . 0.0 110.026 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -59.65 -42.17 92.19 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.803 -0.561 . . . . 0.0 110.97 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' VAL . 62.1 mt -65.35 -41.05 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 121.978 -0.451 . . . . 0.0 109.96 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.78 -41.3 83.43 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.97 -0.456 . . . . 0.0 110.993 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 33' ' ' ILE . 39.5 mt -88.66 -23.43 23.02 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.832 -0.542 . . . . 0.0 112.195 -165.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -49.71 146.68 4.15 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 121.562 -0.712 . . . . 0.0 112.474 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.77 -25.18 26.23 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -88.2 151.96 22.31 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.264 1.032 . . . . 0.0 110.062 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 m -99.96 147.36 25.66 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.831 0.348 . . . . 0.0 110.28 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.4 141.84 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.158 -0.339 . . . . 0.0 110.491 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -134.88 146.43 49.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' VAL . 13.9 m -54.49 138.41 40.44 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.756 -0.59 . . . . 0.0 111.555 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.74 57.43 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.62 152.33 42.45 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 118.674 1.237 . . . . 0.0 110.619 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.37 134.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -136.93 153.29 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.11 -0.369 . . . . 0.0 110.275 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.88 141.1 16.07 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.9 mt -127.8 132.56 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 m -89.84 122.19 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.094 -0.379 . . . . 0.0 110.017 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 57' ' ' VAL . 76.6 mt -128.79 125.73 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.56 32.66 9.3 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.719 -0.613 . . . . 0.0 111.916 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.95 24.17 64.9 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -134.53 127.08 30.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.277 1.039 . . . . 0.0 109.936 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.02 127.59 32.76 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.368 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 52' ' ' ILE . 7.1 p -127.14 133.62 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -95.69 135.22 37.67 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.18 -0.325 . . . . 0.0 110.167 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CD2' HD12 ' A' ' 50' ' ' ILE . 35.6 m-85 -120.1 131.68 55.15 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.097 -0.377 . . . . 0.0 110.23 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -104.51 138.99 40.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.178 -0.326 . . . . 0.0 110.278 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.8 t -79.8 113.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 61.8 t -79.44 -43.4 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -164.25 131.21 3.18 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.572 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.593 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.02 134.05 45.86 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 171.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.6 m-85 -129.2 116.42 18.79 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.19 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.1 Cg_endo -72.94 163.45 89.18 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 C-N-CA 124.689 -0.963 . . . . 0.0 110.105 -15.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 20.3 m -102.22 143.13 25.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.909 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.64 162.98 87.7 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.244 -1.148 . . . . 0.0 110.657 -22.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.28 156.04 45.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.066 -0.396 . . . . 0.0 110.282 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -91.61 142.36 27.71 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 171.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.88 130.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -131.18 165.13 24.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.129 -0.357 . . . . 0.0 110.093 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.76 -29.06 67.91 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.97 -0.457 . . . . 0.0 111.097 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -81.88 -20.48 38.77 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.057 -0.402 . . . . 0.0 111.358 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -68.25 130.72 43.75 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.721 -0.612 . . . . 0.0 110.161 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -88.23 141.43 28.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.1 -0.375 . . . . 0.0 110.064 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.1 mt -126.01 137.55 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -129.9 139.75 51.09 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.819 0.342 . . . . 0.0 110.439 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.1 131.32 46.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.052 -0.405 . . . . 0.0 110.197 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -92.78 139.26 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -147.23 173.57 12.43 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 122.203 -0.31 . . . . 0.0 110.303 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -103.31 157.65 33.39 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.49 1.3 0 O-C-N 123.435 1.229 . . . . 0.0 110.299 179.857 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 . . . . . 0 N--CA 1.502 2.137 0 CA-C-O 120.689 0.28 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.55 153.14 9.41 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.81 128.0 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.27 133.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -145.6 119.54 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.072 -0.393 . . . . 0.0 110.503 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -108.96 151.23 26.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.112 -0.367 . . . . 0.0 110.139 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -152.51 149.78 28.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.064 -0.397 . . . . 0.0 110.748 -176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 42' ' ' VAL . 20.2 tp -123.13 129.97 52.15 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.865 0.364 . . . . 0.0 110.174 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -101.35 117.83 35.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.06 -0.4 . . . . 0.0 110.126 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 61' ' ' VAL . 47.9 mt -116.35 152.45 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -137.81 135.07 18.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.037 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.48 142.9 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.236 1.124 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.0 mt -79.68 -48.85 1.4 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 116.77 -1.586 . . . . 0.0 113.213 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.42 164.34 34.59 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 CA-C-N 121.666 1.631 . . . . 0.0 110.018 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -83.9 96.53 8.84 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.108 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.55 142.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.041 -0.412 . . . . 0.0 110.244 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.06 114.98 18.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.12 -0.363 . . . . 0.0 110.113 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -92.85 142.77 25.95 Favored Pre-proline 0 N--CA 1.497 1.914 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.364 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.8 166.07 7.24 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 O-C-N 123.169 1.089 . . . . 0.0 111.662 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.9 Cg_exo -66.66 -9.32 23.99 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.271 1.314 . . . . 0.0 112.819 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -77.11 -29.43 54.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.273 -0.892 . . . . 0.0 110.683 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.605 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.01 -44.89 94.27 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.65 -0.656 . . . . 0.0 111.109 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -58.94 -32.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.767 -0.583 . . . . 0.0 110.756 -171.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.04 -42.06 73.41 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 122.07 -0.394 . . . . 0.0 110.035 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.5 t -68.66 -40.57 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.599 HG22 HD12 ' A' ' 37' ' ' LEU . 47.3 mm -63.68 -42.57 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.842 177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -58.13 -42.75 86.48 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.822 -0.549 . . . . 0.0 111.166 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 32' ' ' VAL . 64.7 mt -65.49 -41.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.889 -0.507 . . . . 0.0 109.916 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -65.57 -42.64 91.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.982 -0.448 . . . . 0.0 111.054 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 33' ' ' ILE . 70.0 mt -88.68 -28.09 20.82 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 0.0 111.995 -165.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.34 144.99 6.72 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.661 -0.649 . . . . 0.0 112.476 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 -26.3 21.57 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -88.95 155.12 19.7 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 118.139 0.969 . . . . 0.0 110.0 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 m -98.96 147.22 25.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 15' ' ' LEU . 27.9 m -132.03 139.6 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 122.121 -0.362 . . . . 0.0 110.321 -177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -136.26 149.13 48.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 62' ' ' VAL . 15.7 m -54.81 138.86 41.57 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 121.802 -0.561 . . . . 0.0 111.558 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.83 57.52 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 152.0 44.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 118.647 1.223 . . . . 0.0 110.646 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.1 133.09 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.63 151.23 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.283 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.99 140.56 15.5 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 59' ' ' PHE . 83.4 mt -126.44 137.69 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 122.088 -0.654 . . . . 0.0 109.244 175.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 t -90.57 122.0 32.99 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 122.095 -0.378 . . . . 0.0 110.194 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.666 HD12 HG11 ' A' ' 57' ' ' VAL . 80.2 mt -130.08 127.82 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt 51.41 32.53 8.73 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.705 -0.622 . . . . 0.0 111.767 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.27 68.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -133.0 132.71 42.2 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 118.314 1.057 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 127.36 32.52 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.401 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.666 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -127.36 131.76 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -96.25 131.58 42.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.095 -0.378 . . . . 0.0 110.244 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' CD2' HD12 ' A' ' 50' ' ' ILE . 49.2 m-85 -114.41 131.7 56.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 122.067 -0.396 . . . . 0.0 110.144 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -104.97 142.7 34.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.166 -0.334 . . . . 0.0 110.12 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.9 t -84.85 115.55 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 44' ' ' THR . 59.9 t -78.94 -42.4 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -163.93 135.93 4.86 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.704 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.623 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -102.35 134.61 45.37 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 171.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 8.2 m-85 -129.35 114.78 18.4 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.084 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.618 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.0 Cg_endo -72.38 163.91 86.88 Favored 'Cis proline' 0 N--CA 1.502 2.007 0 C-N-CA 124.72 -0.95 . . . . 0.0 110.281 -15.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.623 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 16.1 m -102.14 142.9 25.53 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 119.013 -0.517 . . . . 0.0 110.014 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.11 163.99 84.11 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 124.216 -1.16 . . . . 0.0 110.527 -24.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.92 156.12 45.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 122.08 -0.388 . . . . 0.0 110.441 173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -89.63 140.92 29.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.28 131.61 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.98 174.91 9.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.141 -0.349 . . . . 0.0 110.169 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.61 -28.75 69.58 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.046 -0.409 . . . . 0.0 110.913 169.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -84.3 -20.74 31.62 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.07 -0.394 . . . . 0.0 111.391 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.7 m -75.22 130.84 39.81 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.718 -0.613 . . . . 0.0 110.186 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -88.65 145.0 25.92 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.147 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.4 mt -126.06 131.8 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.97 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.792 0.329 . . . . 0.0 110.341 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -99.4 123.83 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.185 -0.322 . . . . 0.0 110.205 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -94.45 135.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 p -147.47 163.1 37.59 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.151 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -128.71 95.73 31.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 122.13 -0.356 . . . . 0.0 110.155 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.492 1.392 0 O-C-N 123.31 1.163 . . . . 0.0 110.226 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.691 0.282 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.82 68.23 3.57 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.32 138.07 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.075 -0.662 . . . . 0.0 109.252 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.08 118.05 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -88.72 112.85 23.64 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.042 0.449 . . . . 0.0 110.759 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -104.56 151.05 24.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.946 -0.471 . . . . 0.0 110.063 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -151.11 146.8 26.4 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.992 0.425 . . . . 0.0 110.835 -174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 42' ' ' VAL . 20.3 tp -121.09 126.38 49.65 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 170.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.64 119.32 38.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.395 . . . . 0.0 110.065 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 61' ' ' VAL . 34.0 mt -116.49 155.05 29.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -135.43 135.23 21.97 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.01 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.9 142.16 24.91 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.218 1.115 . . . . 0.0 110.221 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 58' ' ' LYS . 24.3 mt -76.85 -48.77 2.69 Favored Pre-proline 0 N--CA 1.503 2.205 0 CA-C-O 116.721 -1.609 . . . . 0.0 113.234 177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.47 162.98 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 CA-C-N 121.72 1.65 . . . . 0.0 109.993 167.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.92 86.61 6.93 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.109 0.481 . . . . 0.0 110.076 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -147.4 142.5 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.95 -0.469 . . . . 0.0 110.129 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.52 133.56 53.99 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.077 -0.389 . . . . 0.0 110.342 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD22 ' CE2' ' A' ' 29' ' ' PHE . 69.7 mt -94.38 145.95 30.64 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.034 -0.416 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.42 163.6 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.238 1.125 . . . . 0.0 111.581 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.0 Cg_exo -66.4 -9.48 24.12 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 O-C-N 123.47 1.247 . . . . 0.0 112.821 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.41 -30.21 53.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.299 -0.876 . . . . 0.0 110.638 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.3 m-85 -60.3 -45.21 94.17 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.677 -0.639 . . . . 0.0 111.126 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.5 p -58.56 -32.91 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 121.744 -0.597 . . . . 0.0 110.69 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.76 -42.67 73.54 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.7 -39.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 HG22 HD12 ' A' ' 37' ' ' LEU . 46.8 mm -63.44 -43.19 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.829 -0.545 . . . . 0.0 109.903 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -58.52 -41.07 84.64 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.8 -0.562 . . . . 0.0 111.133 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.55 -40.48 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.923 -0.485 . . . . 0.0 109.929 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.7 -39.32 91.11 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.038 -0.414 . . . . 0.0 111.017 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 33' ' ' ILE . 18.9 mt -88.42 -29.23 20.37 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.875 -0.515 . . . . 0.0 111.861 -165.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.32 144.22 7.7 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 121.734 -0.604 . . . . 0.0 112.506 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.24 21.53 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.65 154.4 19.99 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.162 0.981 . . . . 0.0 110.074 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.1 m -100.42 147.92 25.32 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 15' ' ' LEU . 27.8 m -130.22 140.26 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 122.123 -0.36 . . . . 0.0 110.236 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -135.81 150.37 49.41 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 m -54.55 136.84 44.43 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.786 -0.571 . . . . 0.0 111.612 -174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.57 58.04 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.73 152.64 38.7 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-N 118.796 1.298 . . . . 0.0 110.765 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.96 134.25 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.55 153.32 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.341 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.14 142.24 16.48 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 59' ' ' PHE . 84.1 mt -128.03 136.2 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.8 t -90.19 122.36 33.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.078 -0.389 . . . . 0.0 110.201 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.648 HD12 HG11 ' A' ' 57' ' ' VAL . 78.9 mt -129.67 125.4 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.5 mt 51.78 32.65 9.89 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 121.819 -0.55 . . . . 0.0 111.816 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 24.23 65.08 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -133.37 129.27 37.19 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.281 1.04 . . . . 0.0 109.987 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.72 126.95 31.93 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.325 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG11 HD12 ' A' ' 52' ' ' ILE . 7.7 p -126.87 132.32 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' CB ' HD12 ' A' ' 20' ' ' LEU . 51.8 mtmt -95.93 133.67 39.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.125 -0.359 . . . . 0.0 110.296 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD12 ' A' ' 50' ' ' ILE . 37.7 m-85 -118.37 131.7 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.052 -0.405 . . . . 0.0 110.198 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -105.86 142.17 36.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.129 -0.357 . . . . 0.0 110.24 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' A' ' 17' ' ' LEU . 60.3 t -84.26 113.88 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.76 -42.98 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -164.78 135.61 4.07 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.641 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -103.97 135.31 45.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 173.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.7 m-85 -129.41 117.32 18.74 Favored Pre-proline 0 N--CA 1.498 1.962 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.023 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.4 Cg_endo -71.22 163.36 85.89 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.191 -16.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 17.2 m -102.45 143.03 25.78 Favored Pre-proline 0 N--CA 1.496 1.839 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.05 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.3 165.0 79.36 Favored 'Cis proline' 0 N--CA 1.501 1.947 0 C-N-CA 124.115 -1.202 . . . . 0.0 110.452 -25.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -142.24 155.82 45.27 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.042 -0.411 . . . . 0.0 110.41 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.1 mtm-85 -91.19 141.94 28.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 171.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.58 127.86 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -131.16 166.71 20.52 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.04 -27.23 65.29 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.984 -0.447 . . . . 0.0 111.187 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.67 -20.48 39.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.989 -0.445 . . . . 0.0 111.321 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -78.07 129.69 35.53 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.638 -0.664 . . . . 0.0 110.135 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -90.29 147.21 23.65 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.135 -0.353 . . . . 0.0 110.185 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.05 135.72 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -126.37 140.85 52.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.15 -0.344 . . . . 0.0 110.419 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.47 128.77 46.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.155 -0.341 . . . . 0.0 110.11 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.5 t -92.58 125.04 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.16 174.8 11.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 172.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -106.35 158.38 32.75 Favored Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.267 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.406 1.214 . . . . 0.0 110.741 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 120.857 0.361 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.16 178.98 25.57 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t 51.16 85.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 O-C-N 121.766 -0.844 . . . . 0.0 110.952 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.31 138.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.5 ptp -90.56 137.57 32.25 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.86 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 p -110.44 152.25 26.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.923 -0.486 . . . . 0.0 110.339 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.78 146.97 27.46 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.975 0.417 . . . . 0.0 110.611 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 42' ' ' VAL . 20.5 tp -130.43 126.86 38.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.112 -0.367 . . . . 0.0 110.039 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.72 131.97 53.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.09 -0.381 . . . . 0.0 110.619 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 61' ' ' VAL . 41.1 mt -122.11 153.47 38.65 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 120.668 0.27 . . . . 0.0 110.345 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -125.79 129.08 24.43 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.817 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.99 137.95 24.94 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.207 1.109 . . . . 0.0 110.289 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 58' ' ' LYS . 25.4 mt -78.76 -48.64 1.7 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.281 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.27 161.85 44.21 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.722 1.651 . . . . 0.0 110.034 167.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -83.46 94.11 7.94 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.048 -0.407 . . . . 0.0 110.106 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.99 140.06 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 122.113 -0.367 . . . . 0.0 110.271 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.09 117.08 28.23 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.602 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -92.73 140.78 23.84 Favored Pre-proline 0 N--CA 1.497 1.907 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.323 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 166.08 8.17 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.191 1.101 . . . . 0.0 111.566 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.8 Cg_exo -66.44 -9.41 23.94 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.527 1.277 . . . . 0.0 112.824 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.72 -29.8 56.38 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 119.1 0.864 . . . . 0.0 110.728 178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.5 m-85 -60.23 -44.57 95.08 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.684 -0.635 . . . . 0.0 111.24 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.7 p -59.13 -33.27 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 O-C-N 121.73 -0.606 . . . . 0.0 110.726 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.11 -41.47 73.94 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.989 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.71 -40.14 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -63.61 -43.14 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.925 -0.485 . . . . 0.0 109.873 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -59.2 -40.7 86.56 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.868 -0.52 . . . . 0.0 111.154 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.91 -41.35 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.921 -0.487 . . . . 0.0 109.954 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -65.39 -43.99 88.92 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.916 -0.49 . . . . 0.0 110.947 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 33' ' ' ILE . 38.0 mt -89.66 -28.65 19.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.924 -0.485 . . . . 0.0 111.831 -166.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.89 147.88 4.62 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 121.629 -0.669 . . . . 0.0 112.34 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.4 -26.62 20.7 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -89.65 154.95 19.56 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.115 0.957 . . . . 0.0 110.199 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 m -99.9 149.8 23.04 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.131 -0.356 . . . . 0.0 110.31 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 15' ' ' LEU . 27.6 m -130.91 144.01 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 122.196 -0.315 . . . . 0.0 110.517 -175.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -133.01 147.98 52.26 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 173.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -55.49 138.26 46.74 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.856 -0.527 . . . . 0.0 111.483 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.88 -17.79 57.74 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.11 152.29 40.87 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 118.679 1.239 . . . . 0.0 110.723 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.53 129.39 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.71 146.01 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.058 -0.401 . . . . 0.0 110.338 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.22 137.83 14.3 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.4 mt -126.27 134.36 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -88.62 122.32 31.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.053 -0.404 . . . . 0.0 110.313 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.0 mt -129.43 130.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.0 mt 51.88 32.62 10.1 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.766 -0.584 . . . . 0.0 111.716 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.03 23.73 65.69 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -137.54 129.02 28.2 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.331 1.065 . . . . 0.0 110.039 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.68 131.75 35.5 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.323 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.33 131.16 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' HD12 ' A' ' 20' ' ' LEU . 51.7 mttp -93.94 128.96 40.54 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.143 -0.348 . . . . 0.0 110.202 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.503 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.8 m-85 -115.5 131.53 56.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.081 -0.387 . . . . 0.0 110.015 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -102.59 138.47 39.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 122.135 -0.353 . . . . 0.0 110.101 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' HD23 ' A' ' 17' ' ' LEU . 57.7 t -79.81 112.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -79.03 -43.95 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -162.34 135.69 6.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -106.74 132.61 52.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 172.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 11.3 m-85 -129.19 116.71 18.84 Favored Pre-proline 0 N--CA 1.497 1.904 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.14 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' O ' HD23 ' A' ' 69' ' ' LEU . 61.6 Cg_endo -73.31 163.19 90.16 Favored 'Cis proline' 0 N--CA 1.501 1.923 0 C-N-CA 124.663 -0.974 . . . . 0.0 110.166 -16.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 56.5 m -102.58 139.82 20.54 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.86 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.39 162.35 90.61 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.365 -1.098 . . . . 0.0 110.681 -16.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.82 155.62 45.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.093 -0.379 . . . . 0.0 110.361 168.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -92.96 142.49 27.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.82 128.49 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.05 179.56 5.93 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 120.835 0.35 . . . . 0.0 110.154 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.02 -26.97 68.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.088 -0.383 . . . . 0.0 110.959 169.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -83.92 -20.59 32.72 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.926 -0.483 . . . . 0.0 111.362 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 m -79.18 128.19 32.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.7 -0.625 . . . . 0.0 110.167 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -89.55 143.41 26.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.074 -0.391 . . . . 0.0 110.031 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.85 139.99 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -129.85 142.09 50.72 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.158 -0.339 . . . . 0.0 110.418 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.77 127.6 45.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.114 -0.366 . . . . 0.0 110.185 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.12 136.73 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.1 p -147.78 97.36 2.81 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.827 0.346 . . . . 0.0 110.108 173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -142.47 96.39 6.32 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 122.037 -0.414 . . . . 0.0 110.197 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 O-C-N 123.302 1.159 . . . . 0.0 110.66 178.7 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.76 163.39 45.88 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.3 t -146.74 135.57 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -114.69 113.69 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 ptp -87.9 116.43 26.06 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -125.13 141.0 52.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.888 -0.507 . . . . 0.0 110.272 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -154.35 146.63 23.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 42' ' ' VAL . 19.9 tp -122.39 129.93 52.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.275 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -101.94 118.26 36.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.098 -0.376 . . . . 0.0 110.003 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 15' ' ' LEU . 46.5 mt -115.97 152.81 32.76 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 120.743 0.306 . . . . 0.0 110.424 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -129.88 128.83 22.96 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.006 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.9 139.16 27.01 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.233 1.123 . . . . 0.0 110.227 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.52 HD12 ' HB3' ' A' ' 58' ' ' LYS . 26.6 mt -79.39 -48.6 1.48 Allowed Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 116.774 -1.584 . . . . 0.0 113.479 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.8 151.78 74.14 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 121.641 1.622 . . . . 0.0 110.258 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -84.66 99.03 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.197 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.04 143.17 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 122.012 -0.43 . . . . 0.0 110.084 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.29 115.61 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.085 -0.384 . . . . 0.0 110.045 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD22 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -94.08 135.16 24.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.336 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.39 165.26 11.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 O-C-N 123.12 1.063 . . . . 0.0 111.227 173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.01 -17.3 59.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 O-C-N 123.449 1.236 . . . . 0.0 112.471 -174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.0 -26.34 61.3 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.497 -0.752 . . . . 0.0 110.766 -174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CE2' HD22 ' A' ' 25' ' ' LEU . 10.9 m-85 -59.41 -54.17 49.79 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.529 -0.732 . . . . 0.0 110.951 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.93 -41.66 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.644 0 O-C-N 121.962 -0.461 . . . . 0.0 110.685 -172.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.17 -39.94 95.07 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 122.029 -0.42 . . . . 0.0 110.635 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 64.4 t -69.45 -41.3 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 HD12 ' A' ' 37' ' ' LEU . 46.6 mm -62.69 -43.87 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.863 -0.523 . . . . 0.0 109.92 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -60.62 -42.37 96.71 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.865 -0.522 . . . . 0.0 110.986 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.44 -42.57 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 O-C-N 121.887 -0.508 . . . . 0.0 109.968 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.73 -42.97 85.41 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.941 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 HG22 ' A' ' 33' ' ' ILE . 23.9 mt -89.62 -27.66 20.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.82 -0.55 . . . . 0.0 111.885 -165.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -50.66 146.67 5.43 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.709 -0.619 . . . . 0.0 112.324 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.15 -26.29 21.74 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -88.78 155.08 19.78 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 117.994 0.897 . . . . 0.0 110.058 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -99.54 147.95 24.79 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 120.897 0.38 . . . . 0.0 110.303 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD13 ' A' ' 15' ' ' LEU . 28.0 m -130.35 140.89 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 122.174 -0.329 . . . . 0.0 110.307 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -135.01 150.05 50.26 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.886 0.374 . . . . 0.0 110.069 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.0 m -54.94 138.13 44.14 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.741 -0.6 . . . . 0.0 111.728 -174.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.65 -17.55 58.2 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -63.55 151.36 41.64 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 118.773 1.286 . . . . 0.0 110.791 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -134.01 131.51 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.97 151.32 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 110.38 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.38 140.43 15.51 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 59' ' ' PHE . 82.7 mt -124.31 136.18 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 t -90.08 119.99 30.89 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.013 -0.429 . . . . 0.0 110.164 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 57' ' ' VAL . 74.6 mt -129.83 128.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 mt 51.48 32.62 9.04 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.732 -0.605 . . . . 0.0 111.782 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.17 23.98 67.31 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -134.03 131.53 38.99 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.313 1.056 . . . . 0.0 110.021 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.84 127.11 32.16 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.355 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 52' ' ' ILE . 7.4 p -127.55 132.77 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 20' ' ' LEU . 52.4 mttp -96.65 134.42 39.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.126 -0.359 . . . . 0.0 110.326 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' HD12 ' A' ' 50' ' ' ILE . 54.2 m-85 -119.82 131.86 55.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.027 -0.421 . . . . 0.0 110.16 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -105.53 143.58 33.5 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.137 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 17' ' ' LEU . 59.6 t -87.64 115.59 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' THR . 62.0 t -79.49 -43.29 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -162.79 136.39 6.03 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.903 0.382 . . . . 0.0 110.404 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 67' ' ' SER . . . -105.48 133.32 50.42 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 172.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 17.5 m-85 -129.25 114.79 18.52 Favored Pre-proline 0 N--CA 1.497 1.905 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.189 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.9 Cg_endo -72.57 163.92 87.25 Favored 'Cis proline' 0 N--CA 1.502 1.971 0 C-N-CA 124.741 -0.941 . . . . 0.0 110.301 -15.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 13.9 m -102.13 142.47 24.64 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 118.98 -0.534 . . . . 0.0 109.955 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 164.35 83.63 Favored 'Cis proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.259 -1.142 . . . . 0.0 110.545 -23.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.17 155.93 45.32 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.962 -0.461 . . . . 0.0 110.435 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -91.18 142.46 27.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 122.043 -0.411 . . . . 0.0 109.904 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.64 133.13 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -131.06 175.21 9.28 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.94 -29.55 70.31 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 122.115 -0.366 . . . . 0.0 110.817 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.3 -20.78 33.78 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.982 -0.449 . . . . 0.0 111.468 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.2 m -73.0 132.95 44.06 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.833 -0.542 . . . . 0.0 110.178 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -87.62 142.01 28.17 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.081 -0.387 . . . . 0.0 110.104 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -126.13 133.01 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.8 m -124.93 142.67 51.31 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.292 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -98.87 124.29 43.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.15 -0.344 . . . . 0.0 110.222 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.1 t -95.49 141.14 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.9 p -147.68 120.2 8.52 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.247 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -151.2 97.2 3.19 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 122.133 -0.355 . . . . 0.0 110.166 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.494 1.508 0 O-C-N 123.228 1.12 . . . . 0.0 110.652 178.56 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.733 0.301 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.11 70.16 0.32 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.5 t -146.72 151.06 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -89.01 145.85 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -145.51 120.46 10.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.171 -0.331 . . . . 0.0 110.431 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.3 p -99.26 152.75 19.57 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -150.43 147.6 27.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.001 -0.437 . . . . 0.0 110.957 -174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 42' ' ' VAL . 4.3 tt -125.36 120.63 31.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.12 122.44 45.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 61' ' ' VAL . 48.6 mt -113.78 154.35 27.52 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.762 0.315 . . . . 0.0 110.475 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -128.48 131.05 23.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 118.932 -0.556 . . . . 0.0 109.756 170.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.59 136.36 19.13 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.233 1.123 . . . . 0.0 110.272 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.62 -49.14 4.93 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 116.83 -1.557 . . . . 0.0 113.133 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 162.83 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 CA-C-N 121.609 1.61 . . . . 0.0 109.958 167.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -83.94 91.26 7.56 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.932 0.396 . . . . 0.0 110.014 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.92 144.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 122.027 -0.42 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.59 127.81 48.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.066 -0.397 . . . . 0.0 110.112 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 29' ' ' PHE . 31.9 mt -93.15 142.96 26.0 Favored Pre-proline 0 N--CA 1.498 1.932 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.283 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.99 162.33 11.51 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 O-C-N 123.201 1.106 . . . . 0.0 111.749 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 30' ' ' VAL . 23.7 Cg_exo -66.75 -9.59 25.15 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 O-C-N 123.484 1.255 . . . . 0.0 112.748 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.71 -29.45 51.31 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.338 -0.851 . . . . 0.0 110.705 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 25' ' ' LEU . 9.8 m-85 -59.81 -43.62 94.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.634 -0.666 . . . . 0.0 111.131 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' PRO . 15.0 p -59.01 -33.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.742 -0.599 . . . . 0.0 110.715 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.93 -41.97 73.91 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.014 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 35' ' ' ILE . 61.1 t -68.64 -39.45 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 HG22 HD12 ' A' ' 37' ' ' LEU . 45.9 mm -64.31 -39.01 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.843 -0.535 . . . . 0.0 109.969 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -58.66 -43.5 89.87 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.668 -0.645 . . . . 0.0 111.128 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 32' ' ' VAL . 74.4 mt -66.14 -45.99 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.999 -0.438 . . . . 0.0 110.054 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 21.2 ptmt -68.3 -33.32 74.12 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.141 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 33' ' ' ILE . 10.1 mt -89.72 -35.38 15.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.857 -0.527 . . . . 0.0 111.398 -169.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -51.3 145.94 7.54 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.701 -0.624 . . . . 0.0 112.349 -171.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.47 -27.68 16.36 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -89.99 155.17 19.29 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 118.018 0.909 . . . . 0.0 110.17 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -99.07 149.34 23.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.471 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 15' ' ' LEU . 27.4 m -131.62 142.25 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 122.181 -0.324 . . . . 0.0 110.231 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -135.79 145.68 46.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 m -54.85 139.89 38.54 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.672 -0.643 . . . . 0.0 111.516 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.82 57.06 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 151.02 44.58 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 118.702 1.251 . . . . 0.0 110.728 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.81 131.71 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.62 147.81 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 122.146 -0.346 . . . . 0.0 110.349 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.2 138.88 14.88 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' A' ' 59' ' ' PHE . 90.0 mt -128.42 139.58 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 122.135 -0.626 . . . . 0.0 109.333 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.4 p -88.61 129.87 35.4 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.122 -0.361 . . . . 0.0 110.366 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 57' ' ' VAL . 81.3 mt -128.9 121.31 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD13 HG22 ' A' ' 52' ' ' ILE . 7.8 mp 51.19 32.81 8.49 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.737 -0.602 . . . . 0.0 111.776 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.24 24.28 61.59 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -131.93 126.0 33.02 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.354 1.077 . . . . 0.0 109.853 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -80.0 130.28 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.051 -0.406 . . . . 0.0 110.259 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 52' ' ' ILE . 11.0 p -125.03 132.26 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.981 -0.45 . . . . 0.0 109.862 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -94.15 127.01 39.73 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.134 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CD2' HD12 ' A' ' 50' ' ' ILE . 30.5 m-85 -112.64 131.34 55.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.026 -0.421 . . . . 0.0 110.043 177.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -104.29 139.98 38.52 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.124 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.7 t -80.43 111.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.68 -41.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -162.8 130.7 3.79 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.711 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.51 137.81 40.26 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -129.54 118.72 19.04 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.13 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.674 ' O ' HD23 ' A' ' 69' ' ' LEU . 60.7 Cg_endo -72.61 163.93 87.29 Favored 'Cis proline' 0 N--CA 1.503 2.07 0 C-N-CA 124.774 -0.928 . . . . 0.0 110.334 -16.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 m -102.06 143.93 27.57 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.04 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.92 164.36 82.75 Favored 'Cis proline' 0 N--CA 1.501 1.935 0 C-N-CA 124.196 -1.168 . . . . 0.0 110.466 -24.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.3 pp -143.53 156.04 44.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.094 -0.378 . . . . 0.0 110.598 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.2 141.25 28.89 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.85 135.09 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.15 176.14 8.51 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.856 0.36 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.88 -28.96 69.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.982 -0.449 . . . . 0.0 110.922 169.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.66 -20.81 32.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.018 -0.426 . . . . 0.0 111.385 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.6 m -75.89 129.21 36.61 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.668 -0.645 . . . . 0.0 110.147 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -88.98 145.37 25.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.122 -0.361 . . . . 0.0 110.044 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -126.18 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.6 m -129.58 143.37 50.8 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.8 0.333 . . . . 0.0 110.528 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.86 122.26 41.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.074 -0.391 . . . . 0.0 110.048 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.2 142.91 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.6 p -146.12 162.49 37.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 122.163 -0.336 . . . . 0.0 110.149 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -122.54 96.39 45.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 122.126 -0.359 . . . . 0.0 110.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 O-C-N 123.228 1.12 . . . . 0.0 110.613 178.1 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.36 129.97 6.1 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -178.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.28 129.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.084 -0.657 . . . . 0.0 109.384 -178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.75 113.95 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -86.82 114.2 23.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.165 0.507 . . . . 0.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.8 p -119.27 142.32 48.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.9 -0.5 . . . . 0.0 110.142 174.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -151.48 144.83 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.908 0.385 . . . . 0.0 110.716 -174.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.69 HD13 HG21 ' A' ' 42' ' ' VAL . 21.3 tp -119.74 125.99 49.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.899 0.38 . . . . 0.0 110.016 171.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -100.91 115.92 31.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.039 -0.413 . . . . 0.0 109.983 177.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 15' ' ' LEU . 48.0 mt -115.27 151.67 34.1 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.752 0.311 . . . . 0.0 110.286 -178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -130.73 128.54 22.48 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-O 118.898 -0.573 . . . . 0.0 109.908 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.49 136.92 16.07 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.226 1.119 . . . . 0.0 110.205 173.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.8 mt -72.38 -48.74 9.56 Favored Pre-proline 0 N--CA 1.503 2.198 0 CA-C-O 116.748 -1.596 . . . . 0.0 113.234 177.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.93 150.5 78.22 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 121.731 1.654 . . . . 0.0 110.145 167.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -84.51 98.95 10.4 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.401 -177.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.91 141.31 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 122.165 -0.334 . . . . 0.0 110.207 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.46 113.54 23.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.105 -0.372 . . . . 0.0 110.093 177.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 45.2 mt -94.04 151.3 39.59 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 122.163 -0.335 . . . . 0.0 110.462 -177.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.57 162.03 13.46 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 O-C-N 123.262 1.138 . . . . 0.0 111.535 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.67 -17.78 60.56 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 O-C-N 123.503 1.265 . . . . 0.0 112.453 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.9 p30 -73.17 -26.37 61.15 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.572 -0.705 . . . . 0.0 110.73 -175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 11.0 m-85 -58.91 -50.89 72.34 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.052 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -55.04 -41.25 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 O-C-N 121.965 -0.46 . . . . 0.0 110.719 -172.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -64.5 -40.67 96.08 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 122.077 -0.389 . . . . 0.0 110.66 176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' ASP . 57.7 t -69.26 -40.85 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.693 HG22 HD12 ' A' ' 37' ' ' LEU . 46.5 mm -62.99 -42.06 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.816 -0.552 . . . . 0.0 109.966 177.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.73 -40.41 83.68 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.82 -0.55 . . . . 0.0 111.169 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 32' ' ' VAL . 73.5 mt -65.66 -42.3 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.927 -0.483 . . . . 0.0 109.852 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -65.24 -42.07 93.71 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.982 -0.449 . . . . 0.0 111.046 178.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.693 HD12 HG22 ' A' ' 33' ' ' ILE . 26.5 mt -89.95 -29.58 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.923 -0.486 . . . . 0.0 111.738 -167.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -50.97 149.07 3.75 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 121.664 -0.647 . . . . 0.0 112.362 -173.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.2 18.82 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -173.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -89.67 154.94 19.56 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 118.04 0.92 . . . . 0.0 110.216 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -100.17 149.57 23.41 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG21 HD13 ' A' ' 15' ' ' LEU . 27.3 m -132.45 146.39 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.052 -0.405 . . . . 0.0 110.466 -176.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -135.98 148.82 48.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 174.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' VAL . 16.0 m -55.27 138.42 45.29 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.736 -0.602 . . . . 0.0 111.502 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.55 -17.79 57.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.26 153.07 39.26 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.703 1.251 . . . . 0.0 110.805 176.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.96 132.11 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.51 154.31 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.312 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.81 138.7 14.99 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 52' ' ' ILE . 81.6 mt -129.74 141.41 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.3 t -88.81 119.2 29.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.019 -0.426 . . . . 0.0 110.075 171.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 50' ' ' ILE . 50.0 mm -125.75 126.17 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 53' ' ' LEU . 1.2 tt 52.68 35.89 19.52 Favored 'General case' 0 N--CA 1.511 2.582 0 O-C-N 121.818 -0.551 . . . . 0.0 111.255 172.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.08 22.96 70.01 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 176.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -143.27 135.28 26.85 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.363 1.081 . . . . 0.0 109.873 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.56 126.77 31.21 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.191 -177.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -96.27 133.95 39.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.163 -0.336 . . . . 0.0 110.247 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 50' ' ' ILE . 32.8 m-85 -119.33 131.78 55.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.038 -0.414 . . . . 0.0 110.199 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -104.54 141.86 35.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.112 -0.367 . . . . 0.0 110.098 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.5 t -84.48 115.09 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 44' ' ' THR . 61.4 t -77.75 -44.06 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -174.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -161.41 136.81 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.473 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.61 131.05 53.47 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 172.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 15.3 m-85 -129.55 120.08 19.59 Favored Pre-proline 0 N--CA 1.497 1.924 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.151 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.658 ' O ' HD23 ' A' ' 69' ' ' LEU . 68.3 Cg_endo -74.09 163.73 89.4 Favored 'Cis proline' 0 N--CA 1.504 2.117 0 C-N-CA 124.764 -0.932 . . . . 0.0 110.276 -17.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -102.11 143.32 26.36 Favored Pre-proline 0 N--CA 1.495 1.808 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.61 162.26 89.22 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 C-N-CA 124.268 -1.138 . . . . 0.0 110.445 -21.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -142.35 155.68 45.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.959 -0.463 . . . . 0.0 110.608 171.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -93.47 143.77 25.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 169.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.8 131.39 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -131.11 177.58 7.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.123 -0.36 . . . . 0.0 110.173 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.49 -27.83 68.86 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 122.085 -0.384 . . . . 0.0 110.921 168.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -82.54 -20.67 36.2 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.903 -0.498 . . . . 0.0 111.48 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -80.14 130.51 35.29 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.711 -0.618 . . . . 0.0 110.199 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.71 144.77 26.05 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 122.099 -0.375 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -126.06 135.66 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 m -125.19 141.1 52.3 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 120.796 0.331 . . . . 0.0 110.274 -177.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.42 126.63 46.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.156 -0.34 . . . . 0.0 110.266 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.5 t -94.73 132.43 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.0 p -148.07 32.91 0.82 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.752 0.311 . . . . 0.0 110.404 173.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -121.55 96.34 47.62 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.93 -0.481 . . . . 0.0 110.231 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.491 1.349 0 O-C-N 123.375 1.197 . . . . 0.0 110.26 178.615 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 . . . . . 0 N--CA 1.508 2.468 0 CA-C-O 120.634 0.254 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.35 178.7 46.98 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -146.4 136.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -114.78 151.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.6 ptp -145.42 119.31 9.31 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.809 0.337 . . . . 0.0 110.482 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -128.82 154.09 46.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.163 -0.336 . . . . 0.0 110.233 178.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.6 153.14 35.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.994 -0.441 . . . . 0.0 110.438 -176.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 17' ' ' LEU . 20.4 tp -131.01 127.73 38.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.149 -0.344 . . . . 0.0 110.183 175.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -98.97 116.28 30.85 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 15' ' ' LEU . 85.2 mt -114.45 149.9 35.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.94 128.66 22.4 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.05 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.74 140.67 21.05 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.251 1.132 . . . . 0.0 110.28 174.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 58' ' ' LYS . 75.6 mt -77.97 -48.73 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.753 -1.594 . . . . 0.0 113.315 176.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.11 159.21 54.81 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 CA-C-N 121.693 1.64 . . . . 0.0 110.143 167.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -84.36 100.68 11.43 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.065 -0.397 . . . . 0.0 110.21 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.92 141.2 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.141 -0.349 . . . . 0.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -111.98 116.67 30.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.118 -0.364 . . . . 0.0 110.075 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 29' ' ' PHE . 44.8 mt -94.41 127.83 42.72 Favored Pre-proline 0 N--CA 1.498 1.95 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.19 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.89 166.16 4.21 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 O-C-N 123.024 1.012 . . . . 0.0 111.942 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 24.3 Cg_exo -66.21 -9.43 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.254 1.303 . . . . 0.0 112.803 -171.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.04 -30.35 58.4 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.185 0.902 . . . . 0.0 110.627 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 25' ' ' LEU . 12.0 m-85 -59.58 -43.75 93.54 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.691 -0.631 . . . . 0.0 111.315 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 27' ' ' PRO . 14.8 p -58.92 -33.45 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 121.802 -0.562 . . . . 0.0 110.736 -171.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.1 -41.42 74.04 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.936 177.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.92 -40.74 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.625 HG22 HD12 ' A' ' 37' ' ' LEU . 46.2 mm -63.81 -40.57 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.869 -0.519 . . . . 0.0 109.98 178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -58.56 -44.34 89.67 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.699 -0.626 . . . . 0.0 111.156 177.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.57 -46.11 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.915 -0.491 . . . . 0.0 110.029 -177.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 33' ' ' ILE . 18.7 ptpt -66.68 -33.09 74.88 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.914 -0.491 . . . . 0.0 111.108 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.625 HD12 HG22 ' A' ' 33' ' ' ILE . 12.7 mt -90.87 -35.7 14.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.835 -0.541 . . . . 0.0 111.441 -170.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -51.65 145.72 8.78 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.79 -0.569 . . . . 0.0 112.444 -170.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.37 17.22 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -173.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.23 155.04 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 118.068 0.934 . . . . 0.0 110.11 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 m -100.45 148.86 24.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.057 -0.402 . . . . 0.0 110.398 -178.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.38 140.79 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.26 149.18 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 173.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 14.1 m -54.92 139.66 39.72 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.751 -0.593 . . . . 0.0 111.562 -175.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.89 56.81 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -64.76 151.44 45.2 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 118.636 1.218 . . . . 0.0 110.779 176.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.01 131.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 48' ' ' ILE . 2.8 pp -137.65 153.72 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.429 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.64 142.85 16.86 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.616 HD12 ' CD2' ' A' ' 59' ' ' PHE . 85.9 mt -128.22 137.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 122.081 -0.658 . . . . 0.0 109.32 176.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.8 p -89.89 122.8 33.27 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.197 171.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.629 HD12 HG11 ' A' ' 57' ' ' VAL . 81.7 mt -128.94 122.3 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 52' ' ' ILE . 5.7 mp 51.19 32.78 8.44 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.771 -0.581 . . . . 0.0 111.863 176.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.61 63.16 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.33 129.08 40.98 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.292 1.046 . . . . 0.0 109.932 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.79 126.99 32.01 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.379 -178.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG11 HD12 ' A' ' 52' ' ' ILE . 7.9 p -125.47 132.94 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 173.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' CB ' HD12 ' A' ' 20' ' ' LEU . 50.3 mttp -94.86 132.18 39.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.152 -0.343 . . . . 0.0 110.116 174.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 50' ' ' ILE . 28.3 m-85 -116.76 131.57 56.92 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.052 -0.405 . . . . 0.0 110.473 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -102.29 137.91 39.92 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 17' ' ' LEU . 61.6 t -84.61 110.87 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 173.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 44' ' ' THR . 60.1 t -79.99 -42.63 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -163.57 129.82 3.21 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.111 -0.368 . . . . 0.0 110.598 -179.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.8 135.92 42.52 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 172.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 9.8 m-85 -129.73 120.29 19.52 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.091 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 69' ' ' LEU . 59.2 Cg_endo -71.97 163.6 86.83 Favored 'Cis proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.719 -0.951 . . . . 0.0 110.276 -17.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -102.1 144.39 28.49 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.838 -0.539 . . . . 0.0 110.116 178.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.28 163.72 82.54 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 C-N-CA 124.047 -1.231 . . . . 0.0 110.46 -26.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 66' ' ' PRO . 4.4 pp -141.73 155.85 45.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.066 -0.396 . . . . 0.0 110.48 173.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -91.44 139.91 30.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 170.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.1 t -80.39 131.69 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -131.1 178.47 6.67 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.97 -29.43 70.24 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.111 -0.368 . . . . 0.0 110.844 169.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -83.55 -20.78 33.21 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.443 -178.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -76.74 125.66 29.65 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.621 -0.674 . . . . 0.0 110.089 175.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -89.77 141.72 28.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.182 -0.324 . . . . 0.0 110.254 -179.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.3 mp -113.78 132.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.8 m -121.69 138.91 54.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.083 -0.386 . . . . 0.0 110.342 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.09 124.96 46.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.157 -0.339 . . . . 0.0 110.241 178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.41 140.68 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -146.87 168.19 22.05 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.289 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -116.9 93.08 40.72 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 122.051 -0.406 . . . . 0.0 110.346 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 O-C-N 123.229 1.12 . . . . 0.0 110.308 179.366 . . . . . . . . 0 0 . 1 stop_ save_